Prof. Felice Petraglia - WordPress.com · 2016-05-16 · 2000-2016 Direttore della Clinica...

F. Petraglia 16.05.2016

1

Curriculum Vitae et Studiorum

Prof. Felice Petraglia Clinica Ostetrica e Ginecologica, Dipart. to di Medicina Molecolare e dello Sviluppo Università degli Studi di Siena Policlinico “Santa. Maria alle Scotte” Viale Bracci, 53100 Siena Telefono :+39 0577 233453- Fax: +39 0577 233454 E-mail: [email protected] Luogo e data di nascita:Salerno, 15/11/1956- Nazionalità : Italiana

CURRICULUM DEGLI STUDI l974 Maturità classica 1980 Laurea in Medicina e Chirurgia (con lode), Università degli Studi di Siena 1984 Specialista Ostetricia e Ginecologia, Università degli Studi di Siena 1987 Specialista Endocrinologia, Università degli Studi di Pavia Periodi di studio post-laurea 1985-1988 Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla,California,USA (Prof. W. Vale) 1993 Clinica Ostetrica e Ginecologica, University of Wien, Vienna, Austria (Prof. P. Husslein)

ATTIVITÀ Didattica ed Accademica Curriculum accademico in ordine cronologico

1981-1982 Medico Interno, Patologia Ostetrica Ginecologica, Università degli Studi di Cagliari 1982-1992 Borsista Cons. Naz. delle Ricerche e tecnico laureato,Clinica Ostetrica e Ginecologica, Università degli Studi di Modena 1992-1997 Professore Associato di Fisiopatologia della Riproduzione Umana, Università degli Studi di Modena 1995-1996 Professore Associato di Fisiopatologia della Riproduzione Umana (missione di studio) Università degli Studi di Pisa 1997-2000 Professore Associato di Ginecologia e Ostetricia Direttore Cattedra di Ginecologia e Ostetricia Presidente Diploma Universitario di Ostetrica/o Direttore Scuola Specializzazione in Ostetricia e Ginecologia Membro del Senato Accademico


2

Vicedirettore del Dipartimento di Scienze Chirurgiche Università degli Studi di Udine

1986-1994 e 1997Attività assistenziale presso la Clinica Ostetrica e Ginecologica Università degli Studi di Modena 1997-2000 Direttore della Clinica Ostetrico-Ginecologica del Policlinico Università degli Studi di Udine

Posizione attuale dal luglio 2000-2016 Professore Ordinario di Ginecologia e Ostetricia Direttore Sezione di Clinica Ostetrica e Ginecologica Direttore Scuola Specializzazione in Ostetricia e Ginecologia Coordinatore di programmi Erasmus con le Università Karolinska (Svezia), Munster (Germania), Paris V (Francia), Utrecht (NL), Valenzia (Spagna), Lisbona (Portogallo). Dal 2002-2008 Direttore Dipartimento di Pediatri, Ostetricia e Medicina della Riproduzione Università di Siena 2000-2010 Coordinatore della Scuola di Dottorato in Biotecnologie Mediche in Ostetricia e Ginecologia Accordo Bilaterale con University of Oxford (UK), University of Utrecht (NL),

University Minais Girais (Belo Horizonte, Brasile) 2011-2014 Direttore Dottorato di Ricerca in Medicina Molecolare Accordo Bilaterale con Univerity of Edinburgh (UK), University of Valencia

(Spagna), Capital University (Pechino, Cina) dal 2003-2011 Direttore del Centro Interdipartimentale Benessere Donna Università degli Studi di Siena dal 2005-2016 Adjunct Professor nel Department of Obstetrics and Gynecology University of Toronto, Toronto, Canada dal 2007-2016 Centro Interuniversitariodi Ricerca sulle Basi Molecolari delle malattie della Riproduzione (CIRMAR) Dal 2015-2016 Guest Professor nel Dipartimento di Obstetrics and Gynecology, Capital University, Pechino, Cina

ATTIVITÀ ASSISTENZIALE


3

2000-2016 Direttore della Clinica Ostetrica e Ginecologica Azienda Ospedaliera Universitaria Senese 2007- 2010- e 2013-2016 Direttore del Dipartimento Assistenza Integrata (DAI) Materno - Infantile Azienda Ospedaliera Universitaria Senese

ATTIVITÀ SCIENTIFICA

Responsabile di progetti di ricerca 1) Responsabile Scientifico dell'Unità Operativa del Consiglio Nazionale delle Ricerche (CNR) Progetto Finalizzato FATMA, Sottoprogetto "Fattori di Malattia nella Patologia Materno-Infantile" su "Studio meccanismi di scatenamento del travaglio di parto", (1991-1995) 2) Responsabile Scientifico progetto bilaterale Italia-USA (CNR) Salk Institute, La Jolla, California. "Role of inhibin and activin in human pregnancy", (1989-1992) Perinatal Division, Department of Obstetrics Gynecology, Wayne State University, Detroit, Michigan: "Preterm labor and placental hormones", (1993-1994) 3) Responsabile progetti di ricerca MURST 60% "Placenta, ormoni e parto", (1992-1997) 4) Coordinatore Nazionale Progetto di Ricerca MIUR COFIN “Evoluzione delle epatopatie croniche in gravidanza: ruolo del sistema activina/inibina/follistatina”, (2000-2001) 5) Coordinatore Nazionale Progetto di Ricerca MIUR COFIN “Identificazione e ruolo dei fattori placentari nell’omeostasi materno-fetale”, (2001-2002) 6) Coordinatore Nazionale Progetto di Ricerca MIUR PRIN “La placenta quale sorgente di markers biofisici, biochimici e molecolari nelle patologie della gravidanza” (2005-2006) 7) Responsabile Progetto Fondazione Monte dei Paschi di Siena “Banca della Placenta” (2002-2003) e del Progetto “Parto Pretermine” (2008-2009). 8) Coordinatore Nazionale Progetto di Ricerca MIUR – PRIN “ Il parto pretermine : la sindrome ostetrica” 9) Coordinatore Nazionale Progetto di Ricerca MIUR – PRIN (MIUR) :“ Il parto pretermine fattori biochimici,biofisici, placentari dell’ unità placentare e fetale (2010-2013)

Brevetti: 1) United States Patent Application Pubblication - Method and System for Fetal Weight Evaluation, US 2007/0038093A1


4

2) European Patent Aplication - Method and System for Foetal Weight Evaluation, EP 1743581A1 3).United States Patent and Trademark office, filed in the United States on April 28, 2008 with deposit number 61/048,412 Consulente per le seguenti Istituzioni:

Ministero dell'Istruzione, dell'Università e della Ricerca, gruppo GEV Università di Padova, Seconda Università di Napoli, Università di Milano, Università La

Sapienza, Campus Biomedico Ministero della Sanità, programma nazionale di Educazione Continua in Medicina E.C.M. Agenzia Italiana del Farmaco (AIFA) (2011-2012) Medical Research Council of Canada Australian Medical Research Council Swiss National Science Foundation The Dutch Research Council The Wellcome Trust (UK) NIH-United States Royal College of of Obstetricians and Gynaecologists (RCOG) (UK) Research Grants Council of Hong Kong United States- Israel Binational Science Foundation Società Scientifiche Nazionali ed Internazionali:

Board of the Society for Endometriosis and Uterine Disorders (SEUD) (2015-2016) President della Society of Gynecological Investigation (SGI) (USA) (2008-2009) Council della SGI (2003-2006) Steerring Committee on Infertility, del WHO (2012-2015) Executive Board della International Federation of Gynecology and Obstetrics (FIGO) (2010-2012) Executive Committee dell’International Society Gynecological Endocrinology (ISGE) (1990-2012) Membership Committee della Endocrine Society (USA) (2003-2006) Council of the European Board and College of Obstetrics and Gynaecology(EBCOG) (2006-2010) Deputy dello Special Interest Group on Reproductive Endocrinology della European Society for Human Reproduction and Embriology (ESHRE) (2003-2007) Scientific Board dell’European Endometriosis League (2012-2014) Scientific Committee of the European Association of Gynaecologists and Obstetricians (EAGO) (1996- 1999) Advisor of Endometriosis Association (2008-2015) Membro Corrispondente della Pontificia Accademia Pro Vita (PAV) ( 2012-2015) Presidente della Italian Society for Reproduction (2011-2012) Comitato Scientifico della Società Italiana di Fisiopatologia della Riproduzione (2001-)


5

Consiglio Direttivo dell’ Associazione Ginecologi Universitari Italiani (AGUI) (2001- 2007) Membro Straniero Onorario della Federacion Argentina de Sociedades de Ginecologia y Obstetricia (F.A.S.G.O) (2013)

Iscritto come Membro della:

Society for Reproductive Investigation (SRI) Society of Endometriosis and Uterine Disorders (SEUD)

European Society for Human Reproduction and Embriology (ESHRE) Società Italiana di Ginecologia e Ostetricia (SIGO) Società Italiana della Riproduzione (SIDR) Riconoscimenti e Premi

- Premio Repubblica di San Marino sulla Medicina della Riproduzione (1988) - Premio “C. Pansini” della Società Italiana di Ostetricia e Ginecologia (1992) - Premio “P.G. Chiodini” della Società Italiana di Endocrinologia (1999) - Premio Internazionale “Arnaldo Bruno” dell’Accademia Nazionale dei Lincei (2001) - Endocrine Society Award for excellence in publications in the Journal of Clinical Endocrinology

and Metabolism (2008) - Fellow –ad-Eundem del Royal College of Obstetricians and Gynaecologists (RCOG) 2010 - McIlrath Guest Professorship, Sydney, Australia (2011 -) - Rogerio A. Lobo Award for the publication on Reproductive Sciences (2014)

ATTIVITÀ EDITORIALI Editore e coeditore di 27 Volumi/Atti congressuali Editor-in-Chief Human Reproduction Udpate (2013-) Journal of Endometriosis (2009-2012) Associate Editor Reproductive Sciences (2007-2012) Journal of Endocrinological Investigation (2004-2012) Human Reproduction Update (2005-2009) Membro dell’Editorial Board Faculty of 1000 Medicine (Section Head for Reproductive Endocrinology) J. Soc. Gynecol. Invest. (2002-2007) Reproductive Sciences (2008-2016) Gynecol. Endocrinol. (1990-)


6

Pren. Neon. Med. (2002-2014) J. Endocrinol. Invest. (1993-1999; 2004-) J. Clin.Endocrinol. Metab. (1995-1999) J. Europ. J. Endocrinol. (1996-2004) Placenta (1993-1998) Contributor for the online Series Up-to-date in Obstetrics and Gynaecology (2000-) Attività come Referee di Riviste Scientifiche Internazionali: -American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology,Reproductive Sciences,

Journal of the Society for Gynecologic Investigation,Fertility and Sterility, British Journal of Obstetrics

and Gynecology,Human Reproduction Update, Human Reproduction , Molecular Human Reproduction, Biology of Reproduction, Reproduction, Fertility and Development, Placenta, Gynecological Endocrinology, -Journal of Clinical Investigation, Life Sciences, Journal of Clinical Endocrinology & Metabolism, Endocrinology, Endocrine Review, Clinical Endocrinology, Journal of Endocrinology,

Neuroendocrinology, Journal of Neuroendocrinology, Endocrine, Acta Endocrinology, European Journal of Endocrinology, Journal of Endocrinological Investigation, Diabetologia, Aging, Cellular and Molecular Neurobiology, Molecular and Cellular Neurosciences, Journal of Hypertension. Autore o coautore di 652 articoli su Riviste Internazionali. Impact Factor totale =2471 Hirsch Index=60 - Numero di citazioni: 15.499

SEMINARI e RELAZIONI A CONGRESSI NAZIONALI ED INTERNAZIONALI

Seminari in Istituzioni Internazionali (n.46) in particolare:

1986 Universite' de Geneve ,Geneve, Switzerland University of California San Diego, San Diego, USA

Columbia University, New York, USA 1988 University of California San Diego, San Diego, USA Fukui University, Fukui, Japon 1989 University of California San Francisco, San Francisco, USA Loma Linda University Loma Linda, USA The Clayton Foundation, Salk Institute, La Jolla, USA 1990 University of California San Diego, San Diego, USA Harvard Med. School, Boston, USA


7

1991 Genentech, San Francisco, USA University of Texas, Dallas, USA Monash University, Melbourne, Australia University of Newcastle, Newcastle, Australia Istitut Gustav Roussy, Paris, France 1992 St. Bartholome's Medical College, Londra, UK University of Reading, Reading, UK 1993 University of Heidelberg, Heidelberg, Germany 1994 Columbia University, New York, USA Mount Sinai Medical School, New York, USA Monash University, Melbourne, Australia Institut Gustave-Roussy, Paris, France 1995 University Western Ontario, London, Canada Peking Union Med. College, University of Xian e University of Shangai, Chine 1996 Emory University Mount Sinai Medical School, New York, USA University of California Irvine, Irvine, USA Salk Institute, La Jolla, USA Yale University, New Haven, USA Kobe University, Kobe, Japan 1999 New York University, New York, USA 2000 Istitut Gustav Roussy, Parigi, Francia 2002 Istitut Gustav Roussy, Parigi, Francia 2004 Penn University Philadelphia, USA Temple University of Philadelphia, Philadelphia, USA George Town University of Washington, Washington, USA 2006 Mount Sinai Hospital, Toronto, Canada 2007 Yale University, New York, USA University of Medicine & Dentistry of New Jersey, Newark, USA 2008 Mother-Child Hospital , Kobe, Japon 2010 New Jersey, Medical Dental School, Newark,USA Mount Sinai Hospital , New York, USA 2011 University of Giessen, Giessen, Germany


8

University of Sydney , Sidney, Australia University of Edimburgh, Edimburgh, UK 2012 University of Guangzhou, Guangdong, China 2014 H.B. Atlee Lecture, Halifax University, Nova Scotia, Canada National University Hospital, Singapore 2015 National University Hospital, Singapore Relazioni invitate a Congressi Internazionali (n.116) in particolare:

1988 First CONRAD Conference on “Non-steroidal Contraceptives”, Norfolk, USA International Symposium on “Placental Protein Hormone, Kobe, Japan VIII Congress International Society of Endocrinology, Kyoto, Japan 1989 Symposium “Gametogenesis and Development Reproductive Organs” Touraine, France IV Congress European Association of Neuroendocrinology, Santiago Campostela, Spain 1990 II Congress International Society of Gynecological Endocrinology, Jerusalem, Israel First Conference on the Primate Endometrium, New York, USA VII World Congress on Human Reproduction, Helsinki, Finland Beijing International Symposium on Reproductive Biology, Beijing ,Chine 1991 International Symposium on “Stress and Reproduction” Port Douglas, Australia IV Meet. Europ. Placenta Group & Rochester Trophoblast Conf., Gwatt, Switzerland The Neuroendocrinology of Sex Steroids, Ulm, Germany 1992 Corticotropin Releasing Factor, London, England XIV World Congress of Fertility and Sterility, Caracas, Venezuela 1993 VIII World Congress on Human Reproduction, Bali, Indonesia II World Congress of Perinatal Medicine, Rome, Italy International Congress on Menopause, Rosario, Argentina IX International Congress on Hormonal Steroids, Dallas, USA 1994 1st Congress of World Placenta Association, Sydney, Australia

1995 10th Congress European Ass. Gynecologists Obstetricians, Montecarlo, France

38th Journee Internationalse Henry-Pierre Klotz, Paris, France World Congress Fertility and Sterility, Montpellier, France

1996 IX World Congress on Human Reproduction, Philadelphia, USA

The Uterus, New York, USA Inhibin, activin and follistatin recent advances and future views, Tokushima, Japan 1997 III World Congress on Labor, Rome, Italy XV Federation Int. Gynecology and Obstetrics World Congress, Copenhagen, Denmark VIII Congress European Neuroendocrine Association, Marseille, France 1998 VI World Gynaecological Endocrinology Congress of ISGE, Crans Montana, Switzerland The Young Woman At the raise of the 21th Century, Athens, Greece 1999 VII World Congress of Gynecological Endocrinology, Buenos-Aires, Argentina V International Congress on Cell Biology of Reproduction, Cambridge, U.K


9

Controversies in Obstetrics, Gynaecology and Infertility, Praga, Rep. Ceka 2000 Endocrine Basis of Reproductive Function, Tampa, USA

International Meeting The Early Human Life, Rome, Italy Human Parturition on the beach – 2000 ICE Satellite, Newcastle, Australia Symposium on Inhibin, Activins and follistatins, Melbourne, Australia Annual Congress of Japan Society of Sterility and Fertility, Kobe, Japan

2001 9th World Congress of Gynaecology and Endocrinology, Hong Kong, Japan

2002 Workshop of the Havermeyer Foundation, Palm Springs, California, USA 2003 Mother and Infant: Perinatal influences on Health, Montreal, Canada 19th Annual meeting ESHRE, Madrid, Spain Key Note Lecture FIGO World Congress Obstetrics and Gynecology, Santiago, Chile 2004 20th Annual Meeting of the European Society of Human Reproduction and Embriology (ESHRE), Berlin, Germany 2005 21th Annual Meeting ESHRE, Copenhagen, Denmark

III Jornadas Internacionales de Ginecotocologia / IV Jornadas de Obstetricia Y Perinatologia en Pysandu, Pysandù, Uruguay

XX Reunião Anual da Federação de Sociedades de Biologia Experimental – FeSBE, Aguas de Lindoia, São Paulo, Brasil

2006 29th Congress of the Polish Gynecological Society of Obstetrics and Gynecology, Poznam, Poland

XVIII FIGO World Congress of Gynecology and Obstetrics, Kuala Lumpur, Malaysia 2007 Annual Congress of the Japanese Society of Obstetrics and Gynecology, Kyoto, Japan Annual Congress of the Hellenic Society of Fertility and Sterility, Thessaloniki, Greece 2008 Munro Kerr Society Spring Meeting, Glasgow U.K Women’s Health & Disease, Athens, Greece Obstetrics Forum, Amsterdam,The Netherlands COGI Symposium, Paris, France 2009 11°th Hellenic Congress in Obstetrics and Gynecology, Athens, Greece 3rd International SGI Summit Sendai, Japan 2010 Controversies in Obstetrics, Gynecology and Infertility, Berlin, Germany ESHRE Campus, Amsterdam, The Netherlands EBCOG Congress, Antwerpen, Belgium Brazilian Endometriosis Society, Sao Paulo,Brasil ESHRE Campus, Valencia, Spain New York Society Ob. Gyn , New York, USA 2011 SGI Annual Meeting, Miami, California, USA 4th International SGI Summit, Belo Horizonte, Brasil World of Endometriosis Society, Montpellier, France European Society of Gynecology, Copenhagen , Denmark ESHRE Campus in Endometriosis, Rome, Italy 2012 6th International Congress on Reproductive Medicine, Moscow, Russia SGI Annual Meeting, San Diego, California, USA FIGO World Congress, Rome, Italy 1 st European Congress on Endometriosis, Siena, Italy


10

Egyptian Fertility and Sterility Society, Cairo, Egypt 2013 SGI Annual Meeting, Orlando,USA II European Congress on Endometriosis, Berlin, Germany German Reproductive Society Meeting, Munster, Germany 2014 SGI Annual Meeting, Florence, Italy Symposium on Women’s Health, Ho Chi Minh City, Vietnam Egyptian Fertility and Sterility Society, Cairo, Egypt 2015 1st Congress of Society Endometriosis and Uterine Disorders, Paris, France Symposium on Women’s Health , Jakarta, Indonesia Asia Pacific Endometriosis Courses, Singapore 2016 2nd Congress of Society Endometriosis and Uterine Disorders, Barcelona, Spain 5 Asian Conference on Endometriosis, Osaka, Japan 11 Congress on Gynecologycal Minimally Invasive Surgery, Peking, China Presidenza di Congressi Internazionali (n.13) in particolare: 2002 – 2nd International Symposium on Progestins, Progesterone Receptor Modulators and

Progesterone Antagonists 2003 – Serono Symposia on “ Inhibins and Related Proteins” 2005 – 1st International SGI Summit on Preterm Birth; 2005– ESHRE Campus Course Molecular Biology for Reproductive Medicine specialist; Siena, Italy 2006 – ESHRE Campus Course Molecular Biology for Reproductive Medicine specialist; Siena, Italy 2007– ESHRE Campus Course Molecular Biology for Reproductive Medicine specialist; Thessaloniki,

GR, 2008- ESHRE Campus Course Molecular Biology for Reproductive Medicine specialist Utrecht,NL 2008 – SGI Forum on “Inflammation and Reproduction” 2009 – 56th Annual Meeting SGI , Glasgow (UK) 2010 – SGI Forum “Sex Steroid Hormones, Genes and Women’s Health“, Siena, Italy 2012 – 1 st European Congress on Endometriosis, Siena, Italy Membro del Comitato Scientifico di Congressi Internazionali(n.25) in particolare: 1989- Brain-Gut Peptides in Reproduction, Pullman (USA), 1994- First Congress World Placenta Associations, Melbourne (Australia), 1996- Mediterranean Gynecological Conference, Eilat (Israele), 1996.- Banff Trophoblast Conference, Banff (Canada), 1997- III International Conference on Reproductive Endocrinology, Pechino (Cina), 1999- X World Congress on Human Reproduction, Salvador Bahia (Brasile), 2000- IV World Congress on Inhibins, activin and follistatins, Melbourne (Australia), 2001- Controversies in Obstetrics Gynecology & Infertility, Parigi,

2003- Mother and Infant: Perinatal influences on health, Montreal, Canada, 2005- 5th International Conference on Reproductive Endocrinology, China


11

Segreteria Scientifica di Congressi Internazionali n. 20 Relazioni invitate a Congressi Nazionali n. 161

Table of the Impact Factor (JCR 2011) of the publications of Prof. Felice Petraglia

Acta Neurol Scand. 2.469 1988, 1990 4.938 Acta Obstet Gynecol Scand 1.771 1990, 1991, 1991, 1994, 2005 8.855 Acupunct Electrother Res 1.30 1982 1.30 Adv Biochem Psychopharmacol No IF 1982, 1987 No IF Adv Clin Chem 3.205 2007, 2008 6.41 Adv Exp Med Biol 1.093 2003 1.093 Am J Med Genet 2.391 1986 2.391 Am J Obstet Gynecol 3.468 1984, 1984, 1987, 1987, 1989, 1990, 1991, 1994,

1996, 1996, 1999, 2001, 2002, 2003, 2006, 2007,2011

58.956

Am J Physiol 4.395 1993 4.395 Am J Psychiatry 12.539 1984 12.539 Am J Reprod Immunol 3.05 2009,2011,2012 9.15 Anal. Quant. Cytol. Histol. 0.413 2005 0.413 Ann NY Acad Sci 3.155 1991,1991,1994, 1997, 1997, 1997, 2000,2009 25.24 Arch Gynecol Obstet 1.277 2012 1.277 Best Pract Res Clin Obstet Gynaecol 1.731 2008 1.731 Neonatology (Biol Neonate) 2.656 2001, 2003 5.312 BJOG (Br J Obstet Gynaecol) 3.407 1999, 2004 6.814 BMC Cancer 3.011 2009 3.011 Cancer 4.771 2002 4.771 Cancer Biol. Ther. 2.636 2003, 2006, 2006 7.908 Cancer Detect. Prev. 2.522 2000 2.522 Cephalalgia 3.43 1983, 1983, 1983, 1985, 1985, 1985, 1987 24.01 Child’s Nerv Syst 1.542 1988 1.542 Circ Res 9,498 2010 9.498 Circulation 14.739 2000 14.739 Climacteric 1.986 2002, 2007, 2010 5.958 Clin. Biochem. 2.076 2007 2.076 Clin. Chem. 7.905 2004, 2006, 2006, 2007, 2007, 2007, 2008, 2008 63.24 Clin Chem Lab Med 2.15 2010 2.15 Clin Dermatol 2.333 2005 2.333 Clin Drug Investig 1.822 2011 1.822 Clin Endocrinol 3.168 1986, 1990, 1993, 1999 12.672 Clin Immunol Immunopathol 4.046 1986 4.046 Clin Neuropharmacol 2.166 1988, 1992, 1993 6.498 Contraception 2.724 1989, 2001, 2009, 2010 10.896 Curr Opin Obstet Gynecol 2.378 1999 2.378


12

Drug Alcohol Depend. 3.383 1985 3.383 Drug Saf 3.634 2002 3.634 Drugs Today 1.277 2009 1.277 Early Hum Dev 2.046 2005 2.046 Endocr Rev 19.929 1996, 2002, 2003, 2010 79.716 Endocrine 1.416 2002 1.416 Endocrinology 4.459 1982, 1985, 1986, 1986, 1987, 1989,2012,2012 35.672 Epilepsia 3.961 1985 3.961 Epilepsy Res 2.29 2003, 2005 4. 58 Eur J Clin Pharmacol 2.845 2004 2.845 Eur J Contracept Reprod Health Care 1.456 1997, 1998 2.912 Eur J Endocrinol (Acta Endocrinol-Copenh)

3.423 1984, 1985, 1986, 1986, 1986, 1987, 1988, 1988, 1992, 1994, 1994, 1995, 1996, 1996, 1996, 1997, 1998, 1998, 1998, 1999, 2000, 2000, 2000, 2000, 2001, 2001, 2002, 2003, 2003, 2004, 2005, 2006, 2007

112.959

Eur J Obstet Gynecol Reprod Biol 1.974 1985, 1986, 1989, 1991, 1993, 2002, 2002, 2003, 2004, 2005, 2007, 2007, 2008, 2009, 2010,2011,2012

33.558

Eur J Pediatr 1.879 2002 1.879 Eur J Pharmacol 2.516 1990 2.516 Eur Neurol 1.811 1983, 1988 3.622 Exp Cell Res 3.589 1993 3.589 Exp Clin Endocrinol 1.693 1987 1.693 Expert Opin Drug Saf 3.015 2006 3.015 Expert Opin Investig Drugs 5.274 2012 5.274 FEBS Lett 3.538 2008 3.538 Fertil Steril 3.564 1985, 1985, 1986, 1986, 1987, 1987, 1989, 1990,

1993, 1993, 1994, 1995, 1995, 1996, 1997, 1998, 1998, 2000, 2001, 2001, 2002, 2002, 2003, 2003, 2003, 2004, 2004, 2006, 2006, 2006, 2007, 2007, 2007, 2008, 2008, 2009, 2009, 2010, 2010, 2010, 2010,2011,2012,2012

156.816

Fetal Diagn Ther 1.048 2008 1.048 Free Radic Biol Med 5.423 2005 5.423 Front Biosci 3.52 2007, 2010 7.04 Front Horm Res 1.712 2001 1.712 Gen Comp Endocrinol 3.267 1992 3.267 Growth Factors 1.65 2002, 2004 3.30


13

Gynecol Endocrinol 1.581 1987, 1987, 1989, 1991, 1993, 1994, 1994, 1995, 1995, 1996, 1996, 1997, 1998, 1998, 1999, 2000, 2000, 2000, 2001, 2001, 2001, 2001, 2001, 2002, 2002, 2003, 2003, 2004, 2004, 2004, 2005, 2006, 2006, 2006, 2007, 2007, 2007, 2009, 2009, 2010,2011,2011,2012,2012,2012,2012

72.726

Gynecol Obstet Invest 1.276 1982, 1985, 1985, 1986, 1987, 1987, 1987, 1988, 1989, 1989, 1990, 1992, 1994, 2002, 2002

19.14

Headache 2.524 1982, 1985 5.048 Horm Metab Res 2.188 1987, 1988, 2003 6.564 Horm Res 2.48 1983, 1987 2.46 Hum Reprod 4.475 1990, 1993, 1994, 1995, 1997, 1998, 1998, 1999,

2000, 2002, 2002, 2003, 2006, 2007, 2009, 2009,2012,2012

80.55

Hum Reprod Update 9.234 2005,2011 18.468 Hypertension 6.207 1997 6.207 Int J Endocrinol 1.867 2009 1.867 Int J Fertil Womens Med 0.640 1997 0.640 Int J Gyneacol Obstet 2.045 2012 2.045 Int J Med Robot 1.588 2004 1.588 Int J Obes 4.691 2007 4.691 Int Rev Neurobiol 2.352 2001 2.352 J Assist Reprod Genet 1.844 2000, 2003 3.688 J Cell Physiol 3.874 2011,2012 7.748 J Clin Endocr Metab 5.967 1982, 1983, 1984, 1985, 1986, 1986, 1986, 1987,

1987, 1988, 1988, 1989, 1990, 1990, 1991, 1991, 1992, 1992, 1993, 1993, 1994, 1995, 1995, 1996, 1996, 1997, 1997, 1997, 1998, 1998, 1998, 1999, 1999, 2000, 2001, 2002, 2002, 2003, 2004, 2005, 2005, 2005, 2007, 2007, 2007, 2008, 2008,2011,2011,2011

298.35

J Clin Lab Anal 1.384 1990 1.384 J Dairy Sci 2.564 2010 2.564 J Endocrinol 3.548 1984, 1985, 1986, 1997, 1998, 200, 2002, 2006 28.384 J Endocrinol Invest 1.566 1981, 1982, 1985, 1986, 1987, 1988, 1988, 1990,

1990, 1990, 1990, 1992, 1993, 1994, 1994, 1995, 1995, 1996, 1996, 1998, 1998, 1998, 1998, 1998, 2000, 2000, 2002, 2003, 2003, 2005, 2006,2011,2012

51.678

J Exp Clin Cancer Res 2.148 2002 2.148 J Hypertens 4.021 2003, 2005, 2006 12.063 J Matern Fetal Neonat Med (Prenatal Neonat. Med)

1.495 2003, 2003, 2003, 2004, 2005,2009, 2009,2012,2013

13.455

J Minim Invasive Gynecol 1.738 2011,2012 3.476 J Mol Histol 1.484 2008 1.484


14

J Neural Transm 2.73 1992 2.73 J Neuroendocrinol 3.138 1993 3.138 J Neurol Neurosur Psychiatry 4.764 1986 4.764 J Pediatr 4.092 2002 4.092 J Pediatr Surg 1.45 2006 1.45 J Perinat Med 1.702 2005 1.702 J Reprod Immunol 2.966 1998, 2009 5.932 J Reprod Med 0.688 1988 0.688 J Steroid Biochem 3.053 1983, 1989, 1995, 1995, 2001 15.265 Lancet 38.278 1983, 2004 76.556 Life Sciences 2.527 1982, 1983, 1983, 1984, 1984, 1986, 1986, 1987,

1993 22.743

Maturitas 2.767 1986, 1987, 1991, 1993, 1997, 1997, 1997, 1998, 1999, 2001, 2002, 2003, 2007

35.971

Med Biol Eng Comput 1.878 2008 1.878 Minerva Anestesiol 2.656 1988, 1988 5.312 Minerva Ginecol No IF 1986, 2004, 2006, 2007, 2007,2011 No IF Mol Cell Endocrinol 4.192 1991, 2000, 2001, 2004, 2004, 2004 25.152 Mol Hum Reprod 3.852 1997, 2000, 2002, 2008,2011 19.26 Mol Reprod Dev 2.532 1995 2.532 Nature 36.28 1987 36.28 Nephron 2.012 1987 2.012 Neurobehav Teratol Toxicol No IF 1985 No IF Neuroendocrinology 2.376 1986, 1987, 1990, 1992, 1993, 1998, 2000,

2002,2011 21.384

Neurology 8.312 1985 8.312 Neuropsychobiology 2.675 1984, 1987, 1992, 1993 10.70 Neurosci Lett 2.105 1987 2.105 Obstet. Gynecol. 4.73 1983, 1986, 1987, 1990, 1994, 2001, 2004,2007 37.84 Oncol Rep 1.835 2004 1.835 Pain 5.777 1984, 1984, 1988 17.331 Pediatr Res 2.7 1989, 1999, 2003 8.1 Pediatrics 5.437 2002, 2006 10.874 Peptides 2.434 1983, 1985, 1985, 1985, 1988, 2004 14.604 Physiol Behav 3.295 1986 3.295 Placenta 3.693 1995, 1995, 1996, 1997, 1997, 1998, 1998, 2000,

2002, 2003, 2006, 2007, 2010,2011,2011 55.395

Plos One 4.092 2009,2012 8.184 Prenat Diag 2.106 2004, 2005, 2009,2012 8.424 Proc Natl Acad Sci U.S.A. 9.432 1989 9.432 Prog Brain Res 3.04 1986 3.04 Prostate 3.485 2002 3.485 Psychiatry Res 2.524 1986, 1991 5.048


15

Psychoneuroendocrinol 5.809 1981, 1992, 1999 17.427 Regul Pept 2.11 1990 2.11 Reprod Biol Endocrinol 2.045 2005, 2006 4.09 Reprod Sci (J Soc Gynecol Invest)

2.444 1999, 2000, 2001, 2001, 2002, 2002, 2002, 2003, 2003, 2004, 2005, 2005, 2007, 2008, 2008, 2009, 2009, 2009, 2009, 2010, 2010, 2010,2011,2011,2012,2012

63.544

Reproduction 3.09 2005 3.09 Science 31.201 1987 31.201 Skin Res Technol 1.71 2007 1.71 Steroids 2.829 2003, 2005, 2010 8.487 Stress 2.476 2001 2.476 Stress Health (Stress Medicine) 1.229 1992 1.229 Subst Alcohol Action Misuse No IF 1985 No IF Transplant Proc 4.003 1998 4.003 Treat Endocrinol No IF 2004 No IF Ultrasound Med Biol 2.293 2003, 2006 4.586 Ultrasound Obstet Gynecol 3.007 1998, 1999, 2001, 2003, 2003, 2008 18.042

TOTAL IMPACT FACTOR: 2471

1. ß-endorphin and ß-lipotropin plasma levels in chronic schizophrenia, primary affective disorders and secondary affective disorders. Brambilla F, Genazzani AR, Facchinetti F, Parrini D, Petraglia F, Sacchetti E, Scarone S, Guastalla A, D'Antona N. Psyconeuroendocrinology, 6: 321-330, 1981. 2. Beta-lipotropin and beta-endorphin in physiological and surgical menopause. Genazzani AR, Facchinetti F, Ricci-Danero MG, Parrini D, Petraglia F, La Rosa R, D'Antona N.

Elenco delle pubblicazioni su riviste Internazionali


16

J. Endocrinol. Invest., 4: 375-378, 1981. 3. Effect of gonadectomy and gonadal steroidreplacement on pituitary and plasma beta-endorphin in rats. Petraglia F, Penalva A, Locatelli V, Cocchi D, Panerai AE, Genazzani AR, Muller EE. Endocrinology, 111: 1224-1229, 1982. 4. Stimulation of ß-endorphin and ß-lipotropin release from the anterior but not the intermediate pituitary lobe in the rat after acute administration of serotonin acting drugs. Petraglia F, Penalva A, Genazzani AR, Muller EE. Life Sciences, 31: 2709-2817, 1982. 5. Central deficiency of ß-endorphin in alcohol addicts. Genazzani AR, Nappi G, Facchinetti F, Mazzella GL, Parrini D, Sinforiani E, Petraglia F, Savoldi F. J. Clin. Endocrinol. Metab., 55: 583-586, 1982. 6. Puerperal breast feeding does not stimulate circulating opioids in human. Genazzani AR, Facchinetti F, Parrini D, Petraglia F, La Rosa R, Puggioni R, D'Antona N. J. Endocrinol. Invest., 5: 367-371, 1982. 7. Opioid plasma levels during labour. Facchinetti F, Centini G, Parrini D, Petraglia F, D'Antona N, Cosmi EV, Genazzani AR. Gynecol. Obstet. Invest., 13: 155-163, 1982. 8. Plasma opioid levels in post-traumatic chronic headache and trigeminal neuralgia: maintained responses to acupuncture. Nappi G, Facchinetti F, Bono G, Micieli G, Parrini D, Petraglia F, Genazzani AR. Headache, 22: 276-279, 1982. 9. Different releasing effects of traditional manual acupuncture and electroacupuncture on proopiocortin-related peptides. Nappi G, Facchinetti F, Legnante G, Parrini D, Petraglia F, Savoldi F, Genazzani AR. Acupunct. Electro-Therap. Res. Int. J., 7: 93-103, 1982. 10. Simultaneous circadian variations of plasma ACTH, beta-lipotropin, beta-endorphin and cortisol. Petraglia F, Facchinetti F, Parrini D, Micieli G, De Luca S, Genazzani AR. Hormone Research, 17: 147-152, 1983. 11. Oestradiol/progesterone imbalance and the premenstrual syndrome. Facchinetti F, Nappi G, Petraglia F, Volpe A, Genazzani AR. Lancet, II: 1302, 1983. 12. Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. Genazzani AR, Facchinetti F, Petraglia F, Pintor C, Puggioni R, Parrini D, Bagnoli F, Corda R. J. Clin. Endocrinol. Metab., 57: 56-61, 1983.


17

13. Opiates and their antagonists modulate luteininzing hormone action outside the blood brain barrier. Panerai AE, Martini A, Casanueva F, Petraglia F, Di Giulio AM, Mantegazza P. Life Sciences, 32: 1751-1756, 1983. 14. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive ß-endorphin concentrations in the rat. Locatelli V, Petraglia F, Penalva A, Panerai AE. Life Sciences, 33: 1711-1717, 1983. 15. Different patterns of central and peripheral ß-EP, ß-LPH and ACTH throughout life. Facchinetti F, Petraglia F, Nappi G, Martignoni E, Antoni G, Parrini D, Genazzani AR. Peptides, 4: 303-309, 1983. 16. Fetomaternal opioids and parturition. Facchinetti F, Bagnoli F, Petraglia F, Parrini D, Sardelli S, Genazzani AR. Obstetrics Gynecology, 62: 764-768, 1983. 17. Beta-endorphin, beta-lipotropin and ACTH levels in cerebrospinal fluid and brain damage in chronic alcoholics. Savoldi F, Mazzella GL, Nappi G, Petraglia F, Facchinetti F, Sinforiani E, Parrini D, Genazzani AR. European Neurology, 22: 265-271, 1983. 18. Correlations between plasma levels of opioid peptides and adrenal androgens in prepuberty and puberty. Genazzani AR, Facchinetti F, Petraglia F, Pintor C, Puggioni R, Parrini D, Bagnoli F, Corda R. J. Ster. Biochem., 19: 891-895, 1983. 19. Serotoninergic agonists increase plasma levels of ß-endorphin and ß-lipotropin in humans. Petraglia F, Facchinetti F, Martignoni E, Nappi G, Volpe A, Genazzani AR. J. Clin. Endocrinol. Metab., 59: 1138-1142, 1984. 20. Gonadal steroid modulation of naloxone-induced LH secretion in the rat. Petraglia F, Locatelli V, Penalva A, Cocchi D, Genazzani AR, Muller EE. J. Endocrinol., 101: 33-39, 1984. 21. Autonomous ß-endorphin secretion from the pituitary neurointermediate lobe: in vivo studies. Petraglia F, Locatelli V, Penalva A, Cella SG, Genazzani AR, Cocchi D. Life Sciences, 34: 1605-1611, 1984. 22. Chronic lisuride treatment decreases ACTH but not ß-EP and ß-LPH plasma levels in children. Petraglia F, Facchinetti F, D'Ambrogio G, D'Attoma G, Nappi G, Genazzani AR. Neuroendocr. Lett., 6: 25-30, 1984.


18

23. Lack of correlation between amniotic fluid and maternal plasma contents of ß-endorphin, B-lipotropin and drenocorticotropin hormone in normal and pathological pregnancies. Genazzani AR, Petraglia F, Parrini D, Nasi A, Angioni G, Facchinetti F, Facchini V, Volpe A. Am. J. Obstet. Gynecol., 148: 198-205, 1984. 24. Increase of proopiomelanocortin-related peptides during subjective menopausal flushes. Genazzani AR, Petraglia F, Facchinetti F, Facchini V, Volpe A, Alessandrini G. Am. J. Obstet. Gynecol., 149: 775-779, 1984. 25. Secretion pattern of endogenous opioids in chronic schizophrenia. Brambilla F, Facchinetti F, Petraglia F, Vanzulli L, Genazzani AR. Am. J. Psychiatry, 141: 1183-1189, 1984. 26. Opioid plasma levels in primary affective disorders: effects of desimipramine therapy. Genazzani AR, Petraglia F, Facchinetti F, Monittola C, Scarone D, Brambilla F. Neuropsychobiology, 12: 78-85, 1984. 27. Progressive impairment of CSF ß-EP levels in migraineurs sufferers. Genazzani AR, Nappi G, Facchinetti F, Micieli G, Petraglia F, Bono G, Monittola C, Savoldi F. Pain, 18: 127-133, 1984. 28. Concomitant increase in nociceptive flexion reflex threshold and plasma opioids following transcutaneous nerve stimulation. Facchinetti F, Sandrini G, Petraglia F, Alfonsi E, Nappi G, Genazzani AR. Pain, 19: 295-303, 1984. 29. Impaired circadian rhythmicity of ß-lipotropin, ß-endorphin and ACTH in heroin addicts. Facchinetti F, Grasso A, Petraglia F, Parrini D, Volpe A, Genazzani AR. Acta Endocrinologica, 105: 148-155, 1984. 30. Central ACTH deficit in degenerative and vascular dementia. Facchinetti F, Nappi G, Petraglia F, Martignoni E, Sinforiani E, Genazzani AR. Life Sciences, 35: 1691-1697, 1984. 31. Impairment of opioid control of luteinizing hormone secretion in menstrual disorders. Petraglia F, D'Ambrogio G, Comitini G, Facchinetti F, Volpe A, Genazzani AR. Fertility Sterility, 43: 534-540, 1985. 32. ß-endorphin and met-enkephalin in peritoneal and ovarian follicular fluids of fertile and postmenopausal women. Petraglia F, Segre A, Facchinetti F, Campanini D, Ruspa M, Genazzani AR. Fertility Sterility, 44: 615-621, 1985. 33. Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. Petraglia F, Baraldi M, Giarre' G, Facchinetti F, Santi M, Volpe A, Genazzani AR.


19

J. Endocrinol., 105: 239-245, 1985. 34. Dermorphin decreases plasma LH levels in human: evidence for a modulatory role of gonadal steroids. Petraglia F, Degli Uberti EC, Transforini G, Facchinetti F, Margutti A, Volpe A, Salvadori S, Tomatis R, Genazzani AR. Peptides, 8: 869-872, 1985. 35. Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climateric and postmenopausal women. Petraglia F, Comitini G, D'Ambrogio G, Volpe A, Facchinetti F, Alessandrini G, Genazzani AR. J. Endocrinol. Invest., 8: 325-330, 1985. 36. Domperidone in defective and insufficient lactation. Petraglia F, De Leo V, Sardelli S, Pieroni ML, D'Antona N, Genazzani AR. Europ. J. Obstet. Gynecol. Reprod. Biol., 19: 281-287, 1985. 37. Neuroendocrine events in postmenopausal women: changes in hypothalamic-pituitary-adrenal and gonadal axis in basal conditions and during hot-flashes. Petraglia F, Facchinetti F, SantoroV, Grasso A, Alessandrini G, Volpe A, GenazzaniAR. New Trends Gynecol. Obstet., 1: 101-111, 1985. 38. Mainly mu opiate receptors are involved in LH and PRL secretion. Panerai AE, Petraglia F, Sacerdote P, Genazzani AR. Endocrinology, 117: 1096-1099, 1985. 39. Dermorphin reduces the metyrapone-evoked release of adrenocorticotropin, ß-endorphin and ß-lipotropin in man. Degli Uberti EC, Petraglia F, Trasforini G, Salvadori S, Margutti A, Bianconi M, Teodori V, Facchinetti F, Tomatis R, Genazzani AR, Pansini R. J. Clin. Endocrinol. Metab., 61: 1018-1022, 1985. 40. ß-endorphin cerebrospinal fluid decrease in untreated Parkinsonian patients. Nappi G, Petraglia F, Martignoni E, Facchinetti F, Bono G, Genazzani AR. Neurology, 35: 1371-1374, 1985. 41. Neurobehavioural and neurochemical abnormalities of prenatally and postnatally lead- exposed rats. Zinc, copper and calcium status. Baraldi M, Zanoli P, Rossi T, Borella P, Caselgrande E, Petraglia F. Neurob. Tox. 7: 499-509, 1985. 42. Impairment of adrenergic-induced proopiomelanocortin-related peptid release in heroi addicts. Facchinetti F, Volpe A, Nappi G, Petraglia F,Genazzani AR.


20

Acta Endocrinologica, 108: 1-5, 1985. 43. Lack of beta-endorphin plasma level rise in oxytocin-induced labour. Genazzani AR, Petraglia F, Facchinetti F, Galli PA, Volpe A. Gynecol. Obstet. Invest., 19: 130-134, 1985. 44. Central opioid receptor activity in patients affected by puerperal, idiopathic and tumoral hyperprolactinemia. De Leo V, Petraglia F, Sardelli S, De Leo M, Genazzani AR, D'Antona N. Gynecol. Obstet. Invest., 19: 160-165, 1985. 45. The effect of an enkephalin analogue on aldosterone secretion in normal subjects. Loche S, Petraglia F, Pintor C, Faedda A, Facchinetti F, Balzano S, Genazzani AR, Corda R. Neuroendocrinol. Lett., 7: 313-318, 1985. 46. Plasma and CSF endorphin levels in primary and symptomatic headaches. Nappi G, Petraglia F, Martignoni E, Facchinetti F, Bono G, Genazzani AR. Headache, 25: 141-145, 1985. 47. CSF ß-EP in headache and depression. Nappi G, Facchinetti F, Martignoni E, Petraglia F, Bono G, Genazzani AR. Cephalalgia, 5: 99-101, 1985. 48. Functional opioid activity variates according to the different fashion of alcohol abuse. Facchinetti F, Petraglia F, Nappi G, Martignoni E, Sinforiani E, Bono G, Genazzani AR. Subst. Alcoh. Action/Misuse, 5: 281-191, 1985. 49. Reduced ACTH, while normal ß-endorphin CSF levels in early epileptic encephalopathies. Facchinetti F, Nalin A, Petraglia F, Galli V, Genazzani AR. Peptides, 6: 31-33, 1985. 50. Pregnancy related changes of opiate receptors identified in rat uterine membranes by 3H- naloxone binding. Baraldi M, Giarre' G, Santi M, Facchinetti F, Petraglia F, Genazzani AR. Peptides, 6: 971-974, 1985. 51. Hypothalamus-pituitary-adrenal axis of heroin addicts. Facchinetti F, Volpe A, Farci G, Petraglia F, Porro C, Barbieri G, Cioni A, Balestrieri A, Genazzani AR. Drug Alcohol Dependence, 15: 361-366, 1985 52. Reduced ACTH content in cerebrospinal fluid ofchildren affected by cryptogenic infantile spasm with hypsarrhytmia.


21

Nalin A, Facchinetti F, Galli V, Petraglia F, Storchi R, Genazzani AR. Epilepsia, 26: 446-449, 1985. 53. GABA inhibits ß-endorphin secretion from the anterior pituitary but not neurointermediate lobe in the rat. Petraglia F, Cella SG, Radice L, Genazzani AR, Muller EE. Endocrinology, 118: 360-366, 1986. 54. Opioids act centrally to modulate stress-induced decrease in LH secretion in the rat. Petraglia F, Vale W, Rivier C. Endocrinology. 119: 2445-2450, 1986. 55. Oestrus cycle-related LH responsiveness to naloxone: effect of high estrogen levels on the activity of opioid receptors. Petraglia F, Locatelli V, Facchinetti F, Bergamaschi M, Genazzani AR, Cocchi D. J. Endocrinol., 108: 89-94, 1986. 56. Naloxone-induced LH secretion in normal, precocious and delayed puberty. Petraglia F, Bernasconi S, Iughetti L, Loche S, Romanini F, Facchinetti F, Marcellini C, Genazzani AR. J. Clin. Endocrinol. Metab., 63: 1112-1116, 1986. 57. Effect of sodium valproate and diazepam on beta-endorphin, beta-lipotropin and cortisol secretion by hypoglycaemic stress in humans. Petraglia F, Bakalakis S, Facchinetti F, Volpe A, Muller EE, Genazzani AR. Neuroendocrinology, 44: 320-325, 1986. 58. Plasma beta-endorphin levels in anovulatory states: changes after treatments for the induction of ovulation. Petraglia F, De Leo V, Di Meo G, Nappi G, Facchinetti F, Genazzani AR. Fertility Sterility, 45: 185-190, 1986. 59. Endogenous opioid peptides in uterine fluid. Petraglia F, Facchinetti F, M'Futa K, Ruspa M, Bonavera JJ, Gandolfi A, Genazzani AR. Fertility Sterility, 46: 247-251, 1986. 60. Somatostatin and oxytocin infusion inhibit the rise of plasma ß-endorphin, ß-lipotropin and cortisol induced by insulin hypoglycemia. Petraglia F, Facchinetti F, D'Ambrogio G, Volpe A, Genazzani AR. Clinical Endocrinology, 24: 609-616, 1986. 61. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Petraglia F, Porro C, Facchinetti F, Cicoli C, Bertellini E, Volpe A, Barbieri GC, Genazzani AR.


22

Life Sciences, 38: 2103-2110, 1986. 62. Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders. Brambilla F, Petraglia F, Facchinetti F, Genazzani AR. Acta Endocrinologica, 112: 381-486, 1986. 63. ß-endorphin concentrations in the hypothalamus, pituitary and plasma of streptozotocin- diabetic rats with and without insulin substitution therapy. Locatelli V, Petraglia F, Tirloni N, Muller EE. Life Sciences, 38: 379-386, 1986. 64. Hyperendorphinemia in obese children and adolescents. Genazzani AR, Facchinetti F, Petraglia F, Pintor C, Corda R. J. Clin. Endocrinol. Metab., 62: 36-40, 1986. 65. Reduction of ß-endorphin levels in the amniotic fluid of heroin addicts. Volpe A, Facchinetti F, Petraglia F, Cioni A, Genazzani AR. Obstetrics Gynecology, 68: 606-609, 1986. 66. Met-enkephalin enhnaces follicle-stimulating hormone-dependent progesterone production from cultured granulosa cells. Facchinetti F, Ruspa M, Turci A, Petraglia F, Segre A, Forabosco A, Genazzani AR. J. Clin. Endocrinol. Metab., 63: 1222-1224, 1986. 67. Dysregulation of plasma pro-opimelanocortin-related peptides in neurotic depression. Genazzani AR, Petraglia F, Sinforiani E, Brambilla F, Facchinetti F, Nappi G. Acta Endocrinologica, 112: 1-6, 1986. 68. Dissociation between CSF and plasma ß-endorphin in major depressive disorders: evidence for a different regulation. Facchinetti F, Petraglia F, Sances G, Garuti C.,Tosca P, Nappi G, Genazzani AR. J. Endocrinol. Invest., 9: 11-14, 1986. 69. Hyperendorphinemia in obesity and relationship to affective state. Facchinetti F, Giovannini C, Barletta C, Petraglia F, Buzzetti R, Burla F, Lazzari R, Genazzani AR, Scavo D. Physiology Behaviour, 36: 937-940, 1986. 70. CSF and plasma levels ofpro-opiomelanocorti-related peptides in reversible ischaemic attaks and strokes. Nappi G, Facchinetti F, Bono G, Petraglia F, Sinforiani E, Genazzani AR. J. Neurol. Neurosurg. Psychiatry, 49: 17-21, 1986. 71. Plasma opioids in the newborn in relation to the mode of delivery. Facchinetti F, Bagnoli F, Sardelli S, Petraglia F, De Leo V, Bracci R, Genazzani AR.


23

Gynecol. Obstet. Invest., 21: 6-11, 1986. 72. Benefits and risks of different hormonal replacement therapies in post-menopausal women. Volpe A, Facchinetti F, Grasso A, Petraglia F, Campanini D, Genazzani AR. Maturitas, 8: 327-334, 1986. 73. Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. Facchinetti F, Comitini G, Petraglia F, Volpe A, Genazzani AR. Eur.J.Obstet.Gynecol.Reprod.Biol. 23: 67-73, 1986. 74. Changes in immunoreactive beta-endorphin, methionine-enkephalin and ACTH in bone marrow cells and fluid from leukemic children. Sardelli S, Petraglia F, Massolo F, Messori A, Santoro V, Facchinetti F, Genazzani AR. Clin. Immunol. Immunopathol., 41: 247-253, 1986. 75. Opioid plasma level in primary affective disorders: effect of chlorimiprramine and cyanoimipramine. Brambilla F, Petraglia F, Facchinetti F, Maggioni M, Genazzani AR. Neuroendocrinol.Lett. 5: 251-255, 1986. 76. Abnormal dexamethasone suppression test in daily chronic headache sufferers. Martignoni E, Facchinetti F, Manzoni GC, Petraglia F, Nappi G, Genazzani AR. Psychiatric Research, 19: 51-57, 1986. 77. Plasma endorphins in Rett syndrome: preliminary data. Facchinetti F, Zappella M, Nalin A, Petraglia F, Bernasconi S, Genazzani AR. Am. J. Med. Gen., 24: 331-338, 1986. 78. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Petraglia F, Sawchenko PE, Rivier J, Vale W. Nature, 328: 717-719, 1987. 79. Localization, secretion and action of inhibin in human placenta. Petraglia F, Sawchenko PE, Lim ATW, Rivier J, Vale W. Science, 237: 187-189, 1987. 80. Corticotropin-releasing factor decreases plasma LH levels in female rats by inhibiting gonadotropin-releasing hormone into hypophysial-portal circulation. Petraglia F, Sutton S, Vale W, Plotsky P. Endocrinology, 120: 1083-1088, 1987. 81. Cyclic AMP, prostaglandins and epinephrine stimulate the secretion of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. Petraglia F, Lim ATW, Vale W.


24

J.Clin.Endocrinol.Metab., 65: 1020-1025,1987. 82. Beta-endorphin and dynorphin participate in the stress-induced release of prolactin in the rat. Petraglia F, Vale W, Rivier C. Neuroendocrinology, 45: 338-342, 1987. 83. Proopiomelanocortin-related peptides and methionine-enkephalin in human follicular fluid: changes during the menstrual cycle. Petraglia F, Di Meo G, Storchi R, Segre A, Facchinetti F, Szalay S, Volpe A, Genazzani A Am. J. Obstet. Gynecol., 157: 142-145, 1987. 84. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states. Petraglia F, De Leo V, Nappi C, Facchinetti F, Montemagno U, Brambilla F, Genazzani A. J. Clin. Endocrinol. Metab., 64: 508-511, 1987. 85. Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia. Petraglia F, Golinelli S, D'Ambrogio G, Comitini G, Facchinetti F, Volpe A, Genazzani AR. Gynecol. Obstet. Invest., 23: 117-121, 1987. 86. Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women. Petraglia F, De Leo V, Sardelli S, Barbaglia V, Mazzullo G, Gioffre' WR, Genazzani AR, D'Antona N. Obstet. Gynecol. Invest., 23: 103-109, 1987. 87. Prolactin secretion following surgery or bromocriptine treatment of prolactinoma. De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N. Obstetrics Gynecology, 69: 99-102, 1987. 88. Opioid regulation of LH secretion in amenorrheic patients following therapy for induction of ovulation Nappi C, Petraglia F, Di Meo G, Minutolo M, Genazzani AR, Montemagno U. Fertility Sterility, 47: 579-582, 1987. 89. Premenstrual fall of plasma ß-endorphin in patients with premenstrual syndrome. Facchinetti F, Martignoni E, Petraglia F, Sances MG, Nappi G, Genazzani AR. Fertility Sterility, 47: 570-573, 1987. 90. Progesterone and progestins modulate ß-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats. Genazzani AR, Petraglia F, Bergamaschi M, Genazzani AD, Facchinetti Fand Volpe A. Gynecological Endocrinology, 1: 61-69, 1987. 91. Feed-back effect of growth hormone on hypothalamic opioid and somatotropin producing neurons. Ganzetti I, Petraglia F, Capuano I, Rosi I, Wehrenberg WB, Muller EE and Cocchi D. J. Endocrinol. Invest., 10: 241-246, 1987


25

92. Ontogeny of pituitary ß-endorphin and related peptides in the human embryo and fetus. Facchinetti F, Storchi AR, Petraglia F, Garuti G, Genazzani AR. Am. J. Obstet. Gynecol., 156: 735-739, 1987. 93. Localization and expression of the three opioid systems. Facchinetti F, Petraglia F , Genazzani AR. Sem. Reprod. Endocrinol., 5: 103-113, 1987. 94. Dexamethasone fails to suppress hyperendorphinemia of obese children. Facchinetti F, Livieri C, Petraglia F, Cortona L, Severi F, Genazzani AR. Acta Endocrinologica , 116: 90-94, 1987. 95. Circulating opioids and plasma renin activity in insulin-dependent diabetics with renal haemodynamic alterations. Solerte SB, Fioravanti M, Petraglia F, Facchinetti F, Aprile C, Genazzani AR, Ferrari E. Nephron 46: 194-198, 1987. 96. Beta-lipotropin is the major component of the plasma opioid response to surgical stress in humans. Porro CA,Facchinetti F, Bertellini E, Petraglia F, Stacca R, Barbieri GC, Genazzani AR. Life Sciences, 41: 2581-2588, 1987. 97. No gradient exists between lumbar and ventricular cerebrospinal fluid B-endorphin. Facchinetti F, Petraglia F, Cicero S, Nappi G, Valentini M, Genazzani AR. Neurosci.Lett., 77: 349-352, 1987. 98. Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan- induced ß-EP, ß-LPH and cortisol secretion. Facchinetti F, Martignoni M, Nappi G, Marini S, Petraglia F, Sandrini G, Genazzani AR. Hormone Research, 27: 42-46, 1987. 99. Plasma beta-endorphin in response to oral glucose tolerance obese patients. Scavo D, Facchinetti F, Barletta C, Petraglia F, Buzzetti R, Monaco M, Giovannini C, Genazzani AR. Horm. Metab. Res., 19: 204-207, 1987. 100. Adrenal steroid responses to naloxone in polycystic ovarian disease. D'Ambrogio G, Facchinetti F, Golinelli S, Setti T, Petraglia F, Genazzani AR. Gynecological Endocrinology 1: 355-361, 1987. 101. Effects of neuroleptic treatments on peripheral opioid secretion. Brambilla F, Facchinetti F, Petraglia F, Smeraldi E, Bellodi L, Brancato V, Genazzani AR. Neuropsychobiology, 18: 68-73, 1987.


26

102. Prostaglandin-induced mid-pregnancy abortion increases plasma and amniotic fluid levels of ß-lipotropin and ß-endorphin. Genazzani AR, Petraglia F, Di Meo G, Santoro V, Facchinetti F, Segre A. Gynecol. Obstet. Invest., 24: 23-27, 1987. 103. Effects of Org OD 14 on pituitary and peripheral ß-endorphin in castrated rats and post menopausal women. Genazzani A R, Petraglia F, Facchinetti F, Genazzani A D,Bergamaschi M, Grasso A, Volpe A. Maturitas, 1: 35-48, 1987. 104. Impairment of the opioidergic control of luteinizing hormone secretion in Turner's syndrome: lack of effect of gonadal steroid therapy. Petraglia F, Larizza D, Maghnie M, Facchinetti F, Volpe A, Bernasconi S, Genazzani AR, Severi F. J. Clin. Endocrinol. Metab., 66: 1024-1028, 1988. 104 bis. Chemical and biological characterization of the inhibin family of protein hormones Vale W. RIVIER, Rivier C.; Hsueh, A; Petraglia F. et al. Recent Progress in Hormone Research,44: 1-34, 1988 105. Expression of proopiomelanocortin-related peptides inhuman follicular fluid. Facchinetti F, Storchi AR, Petraglia F, Volpe A, Genazzani AR. Peptides, 9: 1089-1092, 1988. 106. Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition. Petraglia F, Barletta C, Facchinetti F, Spinazzola F, Monzani A, Scavo D, Genazzani AR. Acta Endocrinologica, 118: 332-336, 1988. 107. Evidence for a dopamine-regulated peripheral source of circulating ß-endorphin. Genazzani A.R, Petraglia F, Facchinetti F, Golinelli S, Otramari P, Santoro V, Volpe A. J. Clin. Endocrinol. Metab., 66: 279-281, 1988. 108. Activity of hypothalamus-pituitary-adrenal axis in children with Hodgkin's disease. Massolo F, Cellini M, Sardelli S, Rota C, Monzani A, Petraglia F, Genazzani AR. J. Ped. Endocrinol., 3: 27-31, 1988. 109. Endocrine response to superovulatory treatment in prepubertal beef heifers: its lack of ability to induce puberty. Bonavera JJ, Tortonese DJ, Doray JM, Petraglia F. Animal Production, 46: 163-167, 1988. 110. Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women. Genazzani AR, Petraglia F, Facchinetti F, Grasso A, Alessandrini G,Volpe A.


27

Gynecol. Obstet. Invest., 26: 153-159 ,1988. 111. Plasma ß-endorphin, free fatty acids and blood lipid changes in type 2 (non-insulin dependent) diabetic patients. Solerte SB, Fioravanti M, Petraglia F, Facchinetti F, Patti AL, Schifino N, Genazzani AR, Ferrari E. J.Endocrinol.Invest., 11: 37-42, 1988. 112. Plasma ß-endorphin resistance to dexamethasone suppression in obese patients. Facchinetti F, Giovannini C, Petraglia F, Barletta C Comitini G, Genazzani AR. J.Endocrinol.Invest., 11: 119-123, 1988. 113. N-terminal ACTH fragments increase the CSF ß-EP content in Alzheimer type dementia. Nappi G, Facchinetti F, Martignoni E, Petraglia F, Sinforiani E, Bono G, Genazzani A.R Acta Neurol.Scand., 78: 146-151, 1988. 114. Aging brain and dementias:changes in central opioids. Nappi G, Sinforiani E, Martignoni E, Petraglia F, Rossi F, Genazzani AR. European Neurology, 28: 217-220, 1988. 115. Absent ß-endorphin response to clonidine in obese children. Facchinetti F, Bernasconi S, Petraglia F, Marcellini C, Iughetti L, Genazzani AR. Horm. Metab. Res., 20: 348-351, 1988. 116. Transient failure of central opioid tonus and premestrual symptoms. Facchinetti F, Martignoni E, Sola D, Petraglia F, Nappi G, Genazzani AR. J. Repr. Med., 33: 663-638, 1988. 117. Neuroendocrine evaluation of central opiate activity in primary headache disorders. Facchinetti F,Martignoni E, Gallai V, Micieli G, Petraglia F, Nappi G, Genazzani AR. Pain, 34: 29-33, 1988. 118. Chemical and biological characterization of the inhibin family of proteins hormones. Vale W, Rivier C, Hsuch A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P, Petraglia F, Plotsky P, Spiess J, Rivier J. Rec. Prog. Horm. Res., 44: 1-34, 1988. 119. Impaired beta-endorphin response to human corticotropin-releasing hormone in obese children.. Bernasconi S, Petraglia F, Iughetti L, Marcellini C, Lamborghini A, Facchinetti F, Genazzani A.R. Acta Endocrinologica, 119: 7-10, 1988. 120. Lack of clinical-EEG effects of naloxone injection on infantile spasms. Nalin A, Petraglia F, Genazzani AR, Frigieri G, Facchinetti F. Child's Nervous System, 4: 365-366, 1988.


28

121. Serotononinergic and dopaminergic control of beta-endorphin secretion in obese children and adolescens . Bernasconi S, Petraglia F, Iughetti L, Facchinetti F, Marcellini C, Mari S, Genazzani AR. J. Ped. Endocrinol., 3: 37-41, 1988. 122. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from human cultured placental cells. Petraglia F, Vaughan J, Vale W. Proc. Natl. Acad. Sci. USA, 86: 5114-5117, 1989. 123. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from human cultured placental cells. Petraglia F, Sutton S, Vale W. Am. J. Obstet. Gynecol., 160: 247-251, 1989. 124. Identification of immunoreactive neuropeptide-Y in human placenta: localization, secretion, and binding sites. Petraglia F, Calzà L, Giardino L, Sutton S, Marrama P, Rivier J, Genazzani AR, Vale W. Endocrinology, 124: 2016-2023, 1989. 125. Plasma and amniotic fluid immunoreactive neuropeptide-Y level changes during pregnancy, labor, and at parturition. Petraglia F, Coukos G, Battaglia C, Bartolotti A, Volpe A, Nappi C, Segre A, Genazzani AR. J. Clin. Endocrinol. Metab., 69: 324-328, 1989. 126. Effect of oral contraceptives or dexamethasone on plasma ß-endorphin during the menstrual cycle. Comitini G, Petraglia F, Facchinetti F, Monaco M, Volpe A, Genazzani AR. Fertility Sterility, 51: 46-50, 1989. 127. Plasma ß-endorphin levels in obese and nonobese patients with policistic ovarian disease. Nappi C, Volpe A, Petraglia F, Facchinetti F, GenazzaniAR , Montemagno U. Europ. J. Obstet. Gynecol. Reprod. Biol., 30: 151-156, 1989. 128. Glucocorticoids but not vasopressin or oxytocin inhibit luteinizing hormone secretion in patients with psychogenic amenorrhea. Monzani A, Petraglia F, De Leo V, Fabbri G, D'AmbrogioG, Volpe A, Genazzani AR. Gynecological Endocrinology, 3: 55-62, 1989. 129. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy. De Leo V, Petraglia F, Bruno MG, Inaudi P, D'Antona N. Gynecol.Obstet.Invest., 27: 94-98, 1989.


29

130. Impairment of dopaminergic and opioidergic activity in policistic ovarian disease patients is restored by treatment for the induction of ovulation. Nappi C, Petraglia F, Di Carlo C, De Rosa R, Zaccardo A, Genazzani AR, Montemagno U. Gynecol. Obstet. Invest., 27: 38-41, 1989. 131.Presence of acetylated and shortened endorphins in human fetal pituitary gland. Facchinetti F, Storchi AR, Petraglia F, Genazzani AR. Pediatric Research, 25: 652-655, 1989. 132. Aging modifies the hormonal responses in women. Fabbri G, Petraglia F, Stacca R, Benatti L, Monzani A, Montanini V, Genazzani AD, Alessandrini G, Genazzani AR. Neuroendocrinol. Lett. 11: 227-234, 1989. 133. Steroid hormones modulate the release of immunoreactive gonadotropin releasing hormone from cultured human placental cells. Petraglia F, Vaughan J, Vale W. J. Clin. Endocrinol. Metab., 70: 1173-1178, 1990. 134. Presence and synthesis of inhibin subunits in human decidua. Petraglia F, Calza L, Garuti G C, Abrate M, Giardino L, Genazzani AR, Vale W, Meunier H. J. Clin. Endocrinol. Metab., 71: 487-492, 1990. 135. Mechanism of action of interleukin-1ß in increasing corticotropin-releasing factor and adrenocorticotropin hormone release from cultured human placental cells. Petraglia F, Garuti G C, De Ramundo B,Angioni S, Genazzani A R, Bilezikjian L M. Am. J. Obstet. Gynecol., 163: 1307-1312,1990. 136. Corticotropin-Realeasing factor and parturition: plasma and amniotic fluid levels and placental binding sites. Petraglia F, Giardino L, Coukos G, Calza L, Vale W, Genazzani AR. Obstetrics Gynecology, 75: 784-789, 1990. 137. Neuroendrocrinology of the human placenta . Petraglia F, Volpe A, Genazzani AR, Rivier J, Sawchenko PE, Vale W. Frontiers in Neuroendocrinology, 11: 6-37,1990. 138. New aspects of placental endocrinology. Petraglia F, Calza L, Garuti GC, Giardino L, De Ramundo BM, Angioni S. J. Endocrinol. Invest., 13: 353-371, 1990. 139. Plasma beta-endorphin and beta-lipotropin levels increase in well trained athletes after competition and non competitive exercise.


30

Petraglia F, Bacchi-Modena A, Comitini G, Scazzina D, Facchinetti F, Fiaschetti D, Genazzani AD, Barletta C, Genazzani AR. J. Endocrinol. Invest., 13: 19-23, 1990. 140. Effect of steroid hormones and antihormones on hypothalamic beta-endorphin concetrations in intact and castrated female rats. Genazzani A R, Petraglia F, Mercuri N, Brilli G, Genazzani AD, Bergamaschi M, De Ramundo BM, Volpe A. J. Endocrinol. Invest., 13: 91-96, 1990. 141. Relationship between cerebrospinal fluid ß-endorphin and plasma pituitary-gonadal hormone levels in women. Nappi C, Petraglia F, Gambardella A, De Masellis G, Di Carlo C, Genazzani AR, Montemagno U. J.Endocrinol. Invest., 13: 149-153, 1990. 142. Estrogens modulate the circadian rhythm of hypothalamic beta-endorphin contents in female rats. Genazzani AR, Trentini GP, Petraglia F, De Gaetani CF, Criscuolo M, Ficarra G, De Ramundo BM, Cleva M. Neuroendocrinology, 52: 221-224, 1990. 143. Presence of ACTH and ß-endorphin immunoreactive molecules in the freshwater snail Planorbarius corneus (L.) (Gastropoda, Pulmonata) and their possible role in phagocytosys. Ottaviani E, Petraglia F, Montagnani G, Cossarizza A, Monti D, Franceschi C. Regulatory Peptides, 27: 1-9, 1990. 144. Norgestimate increases pituitary and hypothalamic concentrations of immunoreactive beta-endorphin. Genazzani AR, Petraglia F, Cleva M, Brilli G, Mercuri N, De Ramundo BM, Volpe A. Contraception, 40: 605-613, 1990. 145. Progestins modulate the action of estrogen on gonadotropin-releasing hormone, Luteinizing hormone and prolactin in the rat. Genazzani AR, Petraglia F, Silferi M, Maietta Lattesa A, Coukos G, Genazzani AD, Artini P, Nappi C, Volpe A. Gynecol. Obstet. Invest., 29: 197-202, 1990. 146. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weigth loss. Genazzani AD, Petraglia F, Fabbri G, Monzani A, Montanini V, Genazzani AR. Fertility Sterility, 54: 222-226, 1990.


31

147. Pregnancy following combined growth hormone-pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea. Volpe A, Coukos G, Artini P, Silferi M, Petraglia F, Boghen M, D'Ambrogio G, Genazzani AR. Human Reproduction, 5: 345-347, 1990. 148. Estimation of instantaneous secretory rate ofluteinizing hormone in women during the menstrual cycle and in men. Genazzani AD, Rodbard D, Forti G, Petraglia F, Baraghini GF, Genazzani AR. Clinical Endocrinology, 32: 573-581, 1990. 149. Cerebrospinal fluid corticotropin-releasing factor levels and stimulation test in dementia of the Alzheimer type. Martignoni E, Petraglia F, Costa A, Monzani A, Genazzani AR, Nappi G. J. Clin. Lab. Anal., 4: 5-8,1990. 150. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. Martignoni E, Petraglia F, Costa A, Bono G, Genazzani AR, Nappi G. Acta Neurol. Scand., 81: 452-456, 1990. 151. The impairment of the hypotalamic-pituitary axes in patient with thalassemia major is not dependent from the therapeutical managment. Sardelli S, Massolo F, Cellini M, Valentini M, Angioni S, Chesi E, Petraglia F, Genazzani AR. Neuroendocrinol. Lett. 12: 479-487, 1990. 152. Oral discomfort and hormone replacement therapy in the post-menopause. Volpe A, Lucenti V, Forabosco A, Boselli F, Maietta Latessa A, Pozzo P, Petraglia F, Genazzani AR. Maturitas, 13: 1-5, 1990. 153. Changes in ß-endorphin in fetal membranes and placenta in normal and pathological pregnancies. Facchinetti F, Garuti G, Petraglia F, Mercantini F, Genazzani AR. Acta Obstet Gynecol Scand., 69: 603-607, 1990. 154. Placental neurohormones: secretion and phisiological implication. Petraglia F. Molecular Cellular Endocrinology, 78: C109-C112, 1991. 155. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-ß production.


32

Petraglia F, Sacerdote P, Cossarizza A, Angioni S, Genazzani AD, Franceschi C, Muscettola M, Grasso G. J. Clin. Endocrinol. Metab. 72: 496-501, 1991. 156. Inhibin subunits in human placenta: localization and messenger ribonucleic acid levels during pregnancy. Petraglia F, Garuti G, Calzà L, Roberts V, Giardino L, Genazzani AR, Vale W, Meunier H. American J. Obstet Gynecol, 165: 750-758, 1991. 157. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. Genazzani AD, Petraglia F, Benatti R, Montanini V, Algeri I, Volpe A, Genazzani AR. J. Clin. Endocrinol. Metab. 72: 1220-25, 1991. 158. The effects of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women. Nappi C, Petraglia F, De Chiara BM, Genazzani AD, Montemagno R, Genazzani AR, Montemagno U. Acta Obstet Gynecol Scand., 70: 435-439, 1991. 159. Acetyl-l-carnitine possible drug in the treatment of hypotalamic amenorrhea. Genazzani AD, Petraglia F, Algeri I, Gastaldi M, Calvani M, Botticelli G, Genazzani AR. Acta Obstet Gynecol Scand., 70: 487-492, 1991. 160. Reduced spinal bone density in young women with amenorrhoeae. Fabbri G, Petraglia F, Segre A, Maietta Latessa A, Galassi MC, Cellini M, Sardelli S, Massolo F, Genazzani AD, Genazzani AR. Europ. J. Obstet & Gynecol Reprod Biol., 41: 117-122, 1991. 161. Specific concordance index defines the physiological lag between LH and progesterone in women during the midluteal phase of the menstrual cycle. Genazzani AD, Guardabasso V, Petraglia F, Genazzani AR. Gynecol. Endocrinol. 5: 175-184, 1991. 162. Clinical safety of the new tri-phasic oral contraceptive pill. Mercuri N, Brilli G, Mancini AC, Botticelli G, Fabbri G, Genazzani AD, Petraglia F, Volpe A, Genazzani AR. Reproduction & Contraception, 3: 25-30, 1991. 163. Stress response in the freshwater snail planorbarius coeneus (L.) (gastropoda, Pulmonata): interaction between CRF, ACTH, and biogenic amines. Ottaviani E, Caselgrandi E, Petraglia F, Franceschi C. General and Comparative Endocrinology, 87: 354-360, 1992.


33

164. Gonadotropin-releasing hormone, inhibin, and activin in human placenta: evidence for a common cellular localization. Petraglia F, Woodruff TK, Botticelli G, Botticelli A, Genazzani AR, Mayo KE, Vale W. J. Clin. Endocrinol. Metab., 74: 1184-88, 1992. 165. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive corticotropin-releasing factor (CRF) and CRF messenger ribonucleic acid. Petraglia F, Tabanelli S, Galassi MC, Garuti G, Mancini AC, Genazzani AR, Gurpide E. J. Clin. Endocrinol. Metab., 74: 1427-31, 1992. 166. Acute beta-interferon or tymopentin administration increases plasma growth hormone and cortisol levels in children. Angioni S, Iori G, Cellini M, Sardelli S, Massolo F, Petraglia F, Genazzani AR. Acta Endocrinologica, 127: 237-41, 1992. 167. Melatonin treatment delays reproductive aging of female rat via the opiatergic system. Trentini GP, Genazzani AR, Criscuolo M, Petraglia F, De Gaetani C, Ficarra G, Bidzinska B, Migaldi M, Genazzani AD. Neuroendocrinology, 56: 364-370, 1992. 168. Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. Martignoni E, Blandini F, Petraglia F, Pacchetti C, Bono G, Nappi G. Journal Neural Transm.,4: 191-205, 1992. 169. Plasma beta-endorphin, cortisol and norepinephrine responses to physical and metabolic stressors in young and elderly humans. Martignoni E, Costa A, Blandini F, Petraglia F, Facchinetti F, Melzi d'Eril GV, Nappi G, Genazzani AR. Stress Medicine, 8: 1-9, 1992. 170. Psychoimmunoendocrine aspects of panic disorder. Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P. Neuropsychobiology, 26: 12-22, 1992. 171. Effect of naltrexone treatment on the treadmill exercise-induced hormone release in amenorrheic women. Botticelli G, Bacchi Modena A, Bresciani D, Villa P, Aguzzoli L, Florio P, Nappi RE, Petraglia F, Genazzani AR. J. Endocrinol. Invest., 15: 839-847, 1992.


34

172. Inhibin and activin in human fetal membranes: evidence for a local effect on prostaglandin release. Petraglia F, Anceschi MM, Calzà L, Garuti GC, Fusaro P, Giardino L, Genazzani AR, Vale W. J. Clin. Endocrinol. Metab., 77: 542-548, 1993. 173. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. Petraglia F, Potter E, Cameron VA, Sutton S, Behan DP, Woods RJ, Sawchenko PE, Lowry PJ, Vale W. J. Clin. Endocrinol. Metab., 77: 919-924, 1993. 174. Activin A and activin B measured in maternal serum, cord blood serum and amniotic fluid during human pregnancy. Petraglia F, Garg S, Florio P, Sadick M, Gallinelli A, Wong WL, Krummen L, Comitini G, Mather J, Woodruff TK. Endocrine Journal, 1: 323-327, 1993. 175. Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y. Petraglia F, Calzà L, Giardino L, Zanni M, Florio P, Nappi C, Genazzani AR. J. Endocrinol. Invest.,16: 201-205, 1993. 176. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Angioni S, Petraglia F, Gallinelli A, Cossarizza A, Franceschi C, Muscettola M, Surico N, Genazzani AR. Life Sci, 23: 1735-1742, 1993. 177. Hormonal treatments modulate pulsatile plasma growth hormone, gonadotropin and osteocalcin levels in postmenopausal women. Mercuri N, Petraglia F, Genazzani AD, Amato F, Sgherzi MR, Maietta-Latessa A, De Leo V, Nappi C, Genazzani AR. Maturitas, 17: 51-62, 1993. 178. Hypothalamic amenorrhea: avidences for a central derangement of hypothalamic-pituitary- adrenal cortex axis activity. Nappi RE, Petraglia F, Genazzani AD, D'Ambrogio G, Zara C, Genazzani AR. Fertil. Steril., 59: 571-576, 1993. 179. Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea. Genazzani AD, Petraglia F, Volpogni C, Gastaldi M, Pianazzi F, Montanini V, Genazzani AR. Fertil. Steril., 60: 465-470, 1993.


35

180. The concomitant release of androstenedione with cortisol and LH pulsatile release distinguishes adrenal from ovarian hyperandrogenism. Genazzani AD, Petraglia F, Pianazzi F, Volpogni C, Genazzani AR. Gynecological Endocrinology, 7: 33-41, 1993. 181. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile, and postmenopausal women. Genazzani AD, Petraglia F, Volpogni C, D'Ambrogio G, Facchinetti F, Genazzani AR. Am. J. Physiol., 27: E776-E781, 1993. 182. Effect of chronic intermittent stress on rat pregnancy and postnatal development. Guo AL, Nappi RE, Criscuolo M, Ficarra G, Amram A, Trentini GP, Petraglia F, Genazzani AR. Eur. J. Obstet.Gynecol. Reprod. Biol., 51: 41-45, 1993. 183. Psychoimmunoendocrine investigation in anorexia nervosa. Brambilla F, Ferrari E, Panerai AE, Manfredi B, Petraglia F, Catalano M, Sacerdote P. Neuropsychobiology, 27: 9-16, 1993. 184. Effects of etoperidone on sympathetic and pituitary-adrenalresponses to diverse stressors in humans. Costa A, Martignoni E, Blandini F, Petraglia F, Genazzani AR, Nappi G. Clin. Neuropharmacol., 2: 127-138, 1993. 185. Effect of different chonic intermittent stressors and acetyl-L-carnitine on hypothalamic B-endorphin and GnRH and on plasma testosterone levels in male rats. Bidzinska B, Petraglia F, Angioni S, Genazzani AD, Criscuolo M, Ficarra G., Gallinelli A, Trentini GP, Genazzani AR. Neuroendocrinology, 57: 985-990, 1993. 186. Acetyl-L-Carnitine effect on pituitary and plasma ß-endorphin responsivenes to different chronic intermittent stressors. Bidzinska B, Petraglia F, Angioni S, Genazzani AD, Criscuolo M, Ficarra G, Gallinelli A, Trentini GP, Genazzani AR. J. Neuroendocrinol., 5: 151-155, 1993. 187. Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhea. Genazzani AD, Petraglia F, Volpogni C, Pianazzi F, Montanini V, D'Ambrogio G, Genazzani AR. Clin. Endocrinol., 39: 607-611, 1993.


36

188. Exposure to low frequency pulsed electromagnetic fields increases interleuin-1 and interleukin-6 production by human peripheral blood mononuclear cells. Cossarizza A, Angioni S, Petraglia F, Genazzani AR, Monti D, Capri M, Bersani F, Cadossi R, Franceschi C. Exp. Cell. Res., 204: 385-387, 1993. 189. Local production and action of follistatin in human placenta. Petraglia F, Gallinelli A, Grande A, Plorio P, Ferrari S, Genazzani AR, Ling N, De Paolo LV. J. Clin. Endocrinol. Metab., 78: 205-210, 1994. 190. Pulsatile functions of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women. Petraglia F, Genazzani AD, Aguzzoli L, Gallinelli A, De Vita D, Caruso A, Genazzani A. Acta Obstet. Gynecol. Scand., 73: 284-289, 1994. 191. Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Petraglia F, Gallinelli A, De Vita D, Lewis K, Mathews L, Woodruff TK. Obstet. Gynecol., 84: 278-282, 1994. 192. Corticotropin-releasing hormone increases prostaglandin F2 activity on human myometrium in vitro. Benedetto C, Petraglia F, Marozio L, Chiarolini L, Florio P, Genazzani AR, Massobrio M. Am. J. Obstetr. Gynecol., 171: 126-131, 1994. 193. The duration of prolactin secretory bursts from the pituitary is indipendent from both prolactin and gonadal steroid plasma levels in women and in men. Genazzani AD, Petraglia F, Volpogni C, Forti G, Surico N, Genazzani AR. J. Endocrinol. Invest., 17: 83-89, 1994. 194. Pituitary and ovarian contents change Interleukin-1 according to estrous cycle and acute stress exposure. Nappi RE, Guo AL, Petraglia F, Bonati ME, Criscuolo M, Ficarra G, Zara C, Genazzani AR. Gynecol. Endocrinol., 8: 259-264, 1994 195. Episodic changes of serum procollagen type I carboxy-terminal propeptide levels in fertile and postmenopausal women. Sgherzi MR, Fabbri G, Maietta Latessa A, Segre A, Volpe A, De Leo V, Genazzani AD, Petraglia F. Gynecol. Obstet. Invest., 38: 60-64, 1994. 196. Intrinsic secretory characteristics of luteinizing hormone and prolactin episodic release during pubertal development.


37

Genazzani AD, Petraglia F, Gastaldi M, Massolo F, Cellini M, Iori G, Surico N., Genazzani AR. Europ. J. Endocrinol., 131: 80-85, 1994. 197. ß-endorphins in essential blefarospasm. Campos EC, Genazzani AR, Petraglia F, Schoenhuber R, Gentilini M, Schiavi C, Aguzzoli L. Neuro-ophtalmology, 14: 237-242, 1994. 198. Episodic release of prolactin in women with weight loss-related amenorrhea. Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Surico N, Genazzani AR. Gynecol. Endocrinol., 8: 95-100, 1994. 199. Acute stress- or lipopolysaccharide-induced corticosterone secretion in female rats is indipendent of the oestrus cycle. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Nappi RE, Palumbo M, Valentini A, Genazzani AR. Europ. J. Endocrinol., 131: 535-539, 1994. 200. Evidence suggesting and additional control mechanism regulating episodic secretion of luteinizing hormone and follicle stimulating hormone in pre-pubertal children and post-menopausal women. Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Massolo F, Genazzani AR. Human Reprod., 9: 1807-1812, 1994. 201. Ontogeny of the circadian rhytm in medial basal hypothalamic ß-endorphin content in female rat. Criscuolo M, De Gaetani C, Ficarra G, Nappi RE, Migaldi M, Petraglia F, Genazzani AR, Trentini GP. J. Endocrinol. Invest., 17: 697-701, 1994. 202. Effect of activin-A on progesterone synthesis in human luteal cells. Di Simone N, Lanzone A, Petraglia F, Ronsisvalle E, Caruso A, Mancuso S. Fertil. Steril., 62: 1157-1161, 1994. 203. Abnormal concentration of maternal serum activin-A in gestational disease. Petraglia F, De Vita D, Gallinelli A, Aguzzoli L, Genazzani AR, Romero R, Woodruff TK. J. Clin. Endocrinol. Metab., 80: 558-561, 1995. 204. Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity on human myometrium in vitro. Petraglia F, Benedetto C, Florio P, D'Ambrogio G, Genazzani AD, Marozio L, Vale W. J. Clin. Endocrinol. Metab., 80: 3073-3076, 1995. 205. Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery. Petraglia F, Aguzzoli L, Florio P, Baumann P, Genazzani AD, Di Carlo C, Romero R.


38

Placenta, 16: 157-164, 1995. 206. Hypertension in pregnancy: changes in activin A maternal serum concentration. Petraglia F, Aguzzoli L, Gallinelli A, FLorio P, Zonca M, Benedetto C, Woodruff K. Placenta, 16: 447-454, 1995. 207. Activin βA subunit is expressed in bovine oviduct. Gandolfi F, Modina S, Brevini TAL, Passoni L, Artini P, Petraglia F, Lauria A. Molecular Reprod and Develop., 40: 286-291, 1995. 208. Corticotropin releasing factor decidualize human endometrial stromal cells in vitro. Interaction with progestin. Ferrari A, Petraglia F, Gurpide E. J Steroid Biochem and Molecular Biol, 54: 251-255, 1995. 209. Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticostertone secretion in rats. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Nappi RE, Palumbo MA, Trentini GP, Purdy RH., Genazzani AR. Gynecol Endocrinol, 9: 1-7, 1995. 210. Evidence for a role for the neurosteroid allopregnanolone in the modulation of reproductive function in femal rats. Genazzani AR, Palumbo MA, de Micheroux AA, Artini PG, Criscuolo M, Ficarra G, Guo AL, Benelli A, Bertolini A, Petraglia F, Purdy RH. Europ J Endocrinol, 133: 375-380, 1995 211. Involvement of m-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats. Degli Uberti EC, Petraglia F, Bondanelli M, Guo AL, Valentini A, Salvadori S, Criscuolo M, Nappi RE, Genazzani AR. J Endocrinol Invest 18: 1-7, 1995. 212. Maternal chronic prenatal stress and neonatal development: experimental studies. Cela V, Guo AL, Criscuolo M, de Micheroux AA, Petraglia F, Genazzani AR Developmental Brain Dysfunction., 8: 127-132, 1995. 213. Naltrexone administration modulates neuroendocrine control of LH secretion in hypothalamic amenorrhea. Genazzani AD, Gastaldi M., Petraglia F., Battaglia C., Surico N., Volpe A., Genazzani A.R.


39

Human Reproduction, 10: 2868-2871, 1995 214. Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Lanzone A, Petraglia F, Fulghesu AM, Ciampelli M, Caruso A, Mancuso S. Fertil Steril, 63: 1195-1199 1995. 215. Naltrexone treatment restores menstrual cycles in patients with weith loss-related amenorrhea. Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Genazzani AR. Fertil Steril , 64: 951-956, 1995. 216.Allopregnanolone concentration in hippocampus of prepuberal rats and female rats throughout estrous cycle. Palumbo MA, Salvestroni C, Gallo R, Guo AL,Genazzani AD, Artini PG, Petraglia F, Genazzani AR. J. Endocrinol. Invest., 18: 853-856, 1995. 217. Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. Genazzani AD, Gastaldi M, Volpe A, Petraglia F , Genazzani AR. Gynecol Endocrinol., 9: 325-334, 1995. 218. Peptide signaling in human placenta and membranes: autocrine, paracrine and endocrine mechanisms. Petraglia F, Florio P, Nappi C, Genazzani AR. Endocrine Reviews, 17: 156-186, 1996. 219. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnant women with pregnancy- induced hypertention. Petraglia F, Florio P, Benedetto C, Gallo R, Woods J, Genazzani AR, Lowry PJ. J. Clinical Endocrinol. Metab., 81: 852-856, 1996. 220. Human placenta fetal membranes express human urocortin mRNA and peptide. Petraglia F, Florio P, Galo R, Simoncini T, Saviozzi M, Di Blasio AM, Vaughan J, Vale W. J.Clinic. Endocrinol. Metab., 81: 3807-3810, 1996. 221. Endocrine role of placenta and related membranes. Petraglia F. European J. Endocrinol., 135: 166-167, 1996.


40

222. Corticotropin-releasing factor and its binding protein: maternal serum in term and preterm deliveries. Berkowitz GS, Lapinski RH, Lockwood CJ, Florio P, Blackmore-Prince C, Petraglia F. Am J Obstet Gynecol, 174: 1477-1483, 1996. 223. Episodic secretion of activin A in pregnant women. Gallinelli A, Gallo R., Genazzani AD, Matteo ML, Caruso A, Woodruff TK, Petraglia F. Europ J Endocrinol, 135: 340-344, 1996. 224. Activin A, corticotropin-releasing factor and prostaglandin F2a increase immunoreactive oxytocin release from cultured human placental cells. Florio P, Lombardo M, Gallo R, DiCarlo C, Sutton S, Genazzani AR, Petraglia F. Placenta, 17: 307-311, 1996. 225. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women. Valentini A, Petraglia F, De Vita D, Nappi C, Margutti A, Degli Uberti EC, Genazzani AR. Am J Obstet Gynecol, 175: 638-642, 1996. 226. Long term GnRH agonist administration revealed a GnRh independent mechanism stimulating FSH discharge in humans. Genazzani AD, Massolo F, Ferrari E, Gandolfi A, Petraglia F, Genazzani AR. Europ. J. Endocrinol., 134: 77-83, 1996. 227. Bicuculline enhances the corticosterone secretion induced by lipopolysaccharide and interleukin -1### in male rats. Guo AL, Petraglia F, Nappi RE, Criscuolo M, Ficarra G, Salvestroni C., Genazzani AD, Trentini GP, Genazzani AR. J. Endocrinol. Invest., 19: 83-87, 1996. 228. Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. Guo AL, Petraglia F, Criscuolo M, Ficarra G, Salvestroni C, Nappi RE, Trentini GP, Genazzani AR. Gynecol Endocrinol., 10: 149-154, 1996. 229. Growth hormone (GH)-releasing hormone-induced GH response in hypotalamic amenorrhea evidence of altered central neuromodulation. Genazzani AD, Petraglia F, Gastaldi M, Gamba O, Corazza F, D'Ambrogio G, Genazzani AR. Fertil Steril, 65: 935-938, 1996. 230. Estrous cycle- and acute stress-related changes of rat ovarian immunoreactive corticotropi-releasing factor. Nappi RE, Petraglia F, Guo AL, Criscuolo M, Trentini GP, Genazzani AR. Gynecol. Endocrinol., 10: 75-82, 1996.


41

231. Effects of hormonal replacement therapy on plasma SHBG, androgen and insulin-like growth factor-1 levels in postmenopausal women. Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR. J Endocrinol Invest, 19: 535-41, 1996. 232.Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. Petraglia F, Luisi S, Benedetto C, Zonca M, Florio P, Casarosa E, Volpe A, Bernasconi S, Genazzani AR. J Clin Endocrinol Metab, 82: 4241-4245, 1997. 233. Inhibin, activin and follistatin in the human placenta: a new family of regulatory proteins. Petraglia F. Placenta, 18: 3-8, 1997. 234. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Petraglia F, Florio P, Simoncini T, Woods RJ, Giuntini A, Gremigni R, Serra GB, Genazzani AR, Lowry PJ. Placenta, 18: 115-119, 1997. 235. High levels of fetal membrane activin BA and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. Petraglia F, Di Blasio AM, Florio P, Gallo R, Genazzani AR, Woodruff TK, Vale W. Journal Endocrinology, 154: 95-101, 1997. 236. Expression of corticotropin-releasing hormone and its R1 receptor in human endometrial stromal cells. Di Blasio AM, Pecori Giraldi F, Viganò P, Petraglia F, Vignali M, Cavagnini F. J Clin Endocrinol Metab., 82: 1594-1597, 1997. 237. Changes in amniotic fluid immuoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor. Florio P, Woods RJ, Genazzani AR, Lowry PJ, Petraglia F. J Clin Endocrinol Metab, 82: 835-838, 1997. 238. Difference of LH and FSH secretory characteristics and degree of concordance between postmenopausal and aging women. Genazzani AD, Petraglia F, Sgarbi L, Montanini V, Hartmann B, Surico N; Biolcati A, Volpe A, Genazzani AR. Maturitas, 26: 133-138, 1997


42

239. Effects of sex steroid hormones on the neuroendocrine system. Genazzani AR, Lucchesi A, Stomati M, Catarsi S, Genazzani AD; Criscuolo M, Petraglia F. Eur J Contrac Reprod Healh Care, 2: 63-69, 1997 240. Endogenous estrogen and acetylcholine-induced vasodilatation in normotensive women. Pinto S, Virdis A, Ghiadoni L, Bernini GP, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A. Hypertension, 29: 268-273, 1997. 241. Hormonal replacement therapy affects calcitonin gene-related peptide and atrial natriuretic peptide secretion in postmenopausal women. Spinetti A, Margutti A, Bertolini S, Bernardi F, Degli Uberti EC, Petraglia F, Genazzani AR. European J Endocrinology, 137: 664-666, 1997. 242. A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrom. Genazzani AD, Petraglia F, Battaglia C, Gamba O, Volpe A, Genazzani AR. Fertil. Steril, 67: 463-468, 1997. 243. Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and H-RH-induced GH secretion in postmenopausal women. Genazzani AD, Gamba O, Nappi L, Volpe A, Petraglia F. Maturitas, 28: 27-33, 1997. 244. Colour Doppler changes and thromboxane production after ovarian stimulation with gonadotrophin-releasing hormone agonist. Battaglia C, Artini PG, Giulini S, Salvatori M, Maxia N, Petraglia F, Volpe A. Human Reproduction,.12: 2477-2482, 1997. 245. Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women. Stomati M, Bersi C, Rubino S, Palumbo M, Comitini G, Genazzani AD, Santre M, Petraglia F, Genazzani AR. Maturitas, 28: 127-135, 1997. 246. Interleukin-2 Production by cultured human granulosa cells. Orvieto R, Genazzani AR, Petraglia F, Schwartz A, Shelef M, Zion Ben R. Int. J. Fertil., 4 : 297-300, 1997. 247. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies.


43

Di Blasio AM, Carniti C, Vigano P, Florio P, Petraglia F, Vignali M. Molecular Human Reprod., 12: 1119-1123, 1997. 248. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissue. High levels of serum activin A in women with endometrial and cervical carcinoma. Petraglia F, Florio P, Luisi S, Gallo R, Carducci A, Viganò P, Di Blasio AM, Genazzani AR, Vale W. J.Clin.Endocrinol.Metab., 83: 1194-1200, 1998. 249. Inhibin B is the major form of inhibin/activin family secreted by granulos cell tumors. Petraglia F, Luisi S, Pautier P, Sabourin JC, Rey R, Lhomme C, Bidart JM. J.Clin.Endocrinol. Metab., 83: 1029-1032, 1998. 250. Low levels of serum inhibin A and inhibin B in women with hypergonadotropic amenorrhea and evidence of high levels of activin A in women with hipothalamic amenorrhea. Petraglia F, Hartmann B, Luisi S, Florio P, Kirchengast S, Genazzani AD, Genazzani AD. Fertil. Steril. 70: 907-912, 1998. 251. Second trimester levels of maternal serum total activin A and placental inhibin/activin α and βA subunit messenger ribonucleic acids in Down syndrome pregnancy. Lambert-Messerlian GM, Luisi S, Florio P, Mazza V, Canick JA, Petraglia F. European J. Endocrinology, 138: 425-429, 1998. 252. Activin A and activin B in extra-embryonic coleomic and amniotic fluids, and maternal serum in early pregnancy. Luisi S, Battaglia C, Florio P, D'Ambrogio G, Taponeco F, Santuz M., Genazzani AR, Petraglia F. Placenta, 19: 435-438, 1998 253. Acute estradiol and progesterone administration reduced cardiovascular and catecholamine responses to menatal stress in menopausal women. Del Rio G, Velardo A, Menozzi R, Zizzo G, Tavernari V, Venneri MG, Marrama P, Petraglia F. Neuroendocrinol., 67: 269-274, 1998. 254. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal fluid throughout the mestrual cycle. Florio P., Luisi S, Viganò P, Busacca M, Fadalti M, Genazzani AR, Petraglia F. Human Reprod., 13: 2606-2611, 1998. 255. Peritoneal fluid of immunoreactive corticotropin-releasing factor (CRF) and CRF-bindin protein (CRF-BP) in healthy and endometriosic women. Florio P, Busacca M, Vignali M, Viganò P, Woods RJ, Lowry PJ, Genazzani AR, Luisi S, Santuz M, Petraglia F. J.Endocrinol. Invest., 21: 37-42, 1998


44

256. Serum levels of dimeric activi A are not a maker of placental tumors in the course of chemotherapy. Florio P, Luisi S, Casarosa E, Genazzani AR, Pautier P, Lhommé C, Bidart JM, Petraglia F. J. Endocrinol.Invest., 21: 166-169, 1998. 257. Estrogen replacement therapy modulates spontaneus GH secretion but does not affect GH-RH induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss. Genazzani AD, Gamba O, Petraglia F. J. Endocrinol.Invest., 21: 353-357, 1998. 258. Regulation of term and preterm labour, Castellina. Italy. Challis J, Petraglia F, Chwalisz K. Placenta, 19: 551-555, 1998. 259. Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insuline-like growth factor binding protein concentrations. Bernardi F, Petraglia F, Seppala M, Spinetti A, Berolini S, Ferdeghini M, Genazzani AR. Human Reproduction,13: 279-284, 1998. 260. Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. Bernardi F, Salvestroni C, Casarosa E, Nappi RE, Lanzone A, Luisi S, Purdy RH, Petraglia F, Genazzani AR Europ. J. Endocrinol., 138: 316-327, 1998 261. The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor. Calogero AE, Palumbo MA, Bosboom AM, Burrello N, Ferrara E, Palumbo G, Petraglia F, D'Agata R. J. Endocrinol., 158: 121-125, 1998. 262. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women. Rubino S, Stomati M, Bersi C, Casarosa E, Luisi M, Petraglia F, Genazzani AR. Maturitas, 28: 251-257, 1998. 263. Hypotalamic amenorrhea and cardiovascular hormones: changes of plasma calcitonin gene-related peptide and atrial natriuretic peptide levels. Bernardi F, Valentini A, Margutti A, Degli Uberti EC, Petraglia F, Genazzani AR. J.Endocrinol. Invest., 21: 251-256, 1998. 264. Beta endorphin response to oral glucose tolerance test in obese and non-obese pre-and postmenopausal women.


45

Stomati M, Bersi C, Bernardi F, Rubino S, Nappi L, Catarsi S, Ferrari A, Spinetti A, Cionini R, Petraglia F, Genazzani AR. Gynecol. Endocrinol., 12: 35-40, 1998. 265. Circulating levels of allopregnanolone in humans: Gender, Age, and endocrine influences. A.R. Genazzani, F. Petraglia, F. Bernardi, E. Casarosa, C. Salvestroni, A. Tonetti, R.E. Nappi, S. Luisi, M. Palumbo, R.H. Purdy, and M. Luisi. J. Clin. Endocrinol. Metab., 83: 2099-2103, 1998. 266. High levels of serum allopregnanolone in Women with premature ovarian failure. Bernardi F, Hartmann B, Casarosa E, Luisi S, Stomati M, Fadalti M, Florio P, Santuz M, Luisi M, Petraglia F, Genazzani AR. Gynecol.Endocrinol, 12: 1-7, 1998. 267. Ultrasonographic patterns of polycystic ovaries: color Doppler and hormonal correlations. Battaglia C, Artini PG, Salvatori M, Giulini S, Petraglia F, Maxia N, Volpe A. Ultrasound Obstet. Gynecol. 11: 332-336, 1998. 268. Effect of acute corticotropin releasing factor on pituitary-adrenocortical responsiveness in elderly women and men. Luisi S, Tonetti A, Bernardi F, Casarosa E, Florio P, Monteleone P, Gemignani R, Petraglia F, M. Luisi, A.R. Genazzani. J. Endocrinol.Invest., 21: 449-453, 1998. 269. Corticotropin-releasing hormone facilitates early survival of discordant (bovine-to-rat) islet xenografts. Lupi R, Marchetti P, Coppelli A, Giannarelli R, Petraglia F, Luisi S, Del Guerra S, Tellni C, Florio P, Genazzani A, Viacava P, Navalesi R. Transplant Proc., 30: 2481-2483, 1998. 270.Contraception as prevention and therapy: sex steroids and the brain. Stomati M, Genazzani AD, Petraglia F, Genazzani AR. Europ. Journ. of Contraception and Reprod. Health Care, 3: 21-28, 1998. 271. Paracrine regulation of human placenta: control of hormonogenesis. Petraglia F, Santuz M, Florio P, Simoncini T, Luisi S, Plaino L, Genazzani AR, Genazzani AD, Volpe A. J. Reprod. Immun., 39: 221-233, 1998. 272.Influence of age and sex on serum concentrations of total dimeric activin A.


46

Loria P, Petraglia F, Concari M, Bertolotti M, Martella P, Luisi S, Grisolia C, Foresta C, Volpe A, Genazzani AR, Carulli N. Europ. Journ. of Endo., 139: 487-492, 1998. 273. Acute infusion of naloxone, and opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women. Genazzani AD, Menozzi R, Del Rio G, Luisi S, Petraglia F, Genazzani AR. Fertil.Steril., 70: 924-926, 1998. 274. Increased midtrimester amniotic fluid activin A: A risk factor for subsequent fetal death. F. Petraglia, R. Gomez, S. Luisi, P. Florio, J.E. Tolosa, M. Stomati, R. Romero. Am. J. Obstet.Gynecol., 180: 194-197, 1999. 275. Urocortin stimulates placental adrenocorticotropin and prostglandin release and myometrical contractily. Petraglia F, Florio P, Benedetto C, Marozio L, Di Blasio AM, Ticconi, C, Piccione E, Luisi S, Genazzani AR, Vale W. J. Clin. Endocrinol. Metab., 84(4): 1-4, 1999. 276. Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. Simoncini, T, Apa R, Stomati M, Reis F, Driul L, Lanzone A, Genazzani AR, Petraglia F. J. Clin. Endocrinol. Metab.,84: 2802-2806, 1999. 277. Putative role of placental corticotropin-releasing factor in the mechanisms of human parturition. Reis F, Fadalti M, Florio P, Petraglia F. J. Soc. Gyn. Invest, 6: 109-119, 1999. 278. Parturition in two pregnant women with Addison's disease: changes of plasma corticotropin releasing factor levels. Stomati M, Springolo F, Plaino L, Florio P, Fadalti M, Pezzani I, Petraglia F. Prenatal and Neonatal Medicine, 4: 139-142,1999. 279. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR. Gynecol. Endocrinol., 13: 15-25, 1999. 280. Inhibin B levels in azoospermic subjects with cytologically characterized testiculopathy. Foresta C., Bettella A, Luisi S, Petraglia F, Pistorello M.


47

Clin. Endocrinol, 50: 695-701, 1999. 281. Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery. Florio P, Benedetto C, Luisi S, Santuz M, Di Carlo C, Marozio L, Genazzani AR, Petraglia F. British. J. Obst. Ginaecol., 106: 1061-1065, 1999. 282. Changes of serum allopregannolone levels in the first two years of life and during pubertal development. Fadalti M, Ferrari E, Petraglia F, Luisi S, Bernardi F, Casarosa E, Luisi M, Saggese G, Genazzani AR, Bernasconi S. Ped. Res, 46: 323-327, 1999. 283. Inhibins: paracrine and endocrine effects in female reproductive function. Petraglia F, Zanin E, Faletti A, Reis F. Curr. Op. Ob.Gyn, 11: 241-247, 1999. 284. Human mammary gland and breast carcinoma contain immunoreactive inhibin/subunits: evidence for a secretion into cystic fluid. Di Loreto C, Reis F, Cataldi P, Zuiani C, Luisi S, Beltrami CA, Petraglia F. Eur. J. Endocrinol., 141: 190-194, 1999. 285. Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients. Battaglia C, Salvatori M, Maxia N, Petraglia F, Facchinetti F, Volpe A. Human Reprod., 14: 1690-1697, 1999. 286. Lack of gestation-related changes of urocortin gene expression in human placenta. Florio P, Rivest S, Reis FM, Simoncini T, Martinelli P, Genazzani AR, Petraglia F. Prenatal Neonatal Medicine, 4: 296-300,1999. 287. Antagonism by pivagabine of stress-induced changes in GABA receptor function and corticotropin-releasing factor concentrations in rat brain. Serra M, Concas A, Mostallino MC, Chessa MF, Stomati M, Petraglia F, Genazzani AR, Biggio G. Psychoneuroendocrinology, 24: 269-284,1999. 288. GH, IGFBP-1, and IGFBP-3 response to oral glucose tolerance test in perimenopausal women: no influence of body mass index. Bernardi F, Petraglia F, Seppala M, Spinetti A, Bertolini S, Driul L, Ferdeghini M, Genazzani AR. Maturitas, 33: 163-169, 1999. 289. Polycystic ovary syndrome: it is always bilateral? Battaglia C, Regnani G, Petraglia F, Primavera MR, Salvatori M, Volpe A.


48

Ultrasound Obstet Gynecol, 14: 183-187, 1999. 290. Allopregnanolone concentrations and premestrual syndrome. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR. Eur. J. Endo., 142: 269-273, 2000. 291. Human placenta, chorion, amnion and decidua express different corticotropin-releasing factor receptor messenger RNA variants. Florio P, Franchini A, Reis FM, Pezzani I, Ottaviani E, Petraglia F. Placenta, 21: 32-37, 2000. 292. Activin A stimulates insulin secretion in cultured human pancreatic islets. Florio P, Luisi S, Marchetti P, Lupi R, Santuz M, Falaschi C, Sugino H, Navalesi R, Genazzani AR, Petraglia F. J. Endocrinol. Invest., 23: 231-234, 2000. 293. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Meczekalski B, Tonetti A, Monteleone P, Bernardi F, Luisi S, Stomati M, Luisi M, Petraglia F, Genazzani AR. Eur. J. Endo., 142: 280-285, 2000. 294. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. D’Antona D, Reis FM, Benedetto C, Evans LW, Groome NP, de KretserD, Wallace EM, Petraglia F. J. Endo., 165: 157-162, 2000. 295. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia F, Genazzani AR. Eur. J. Endo., 142: 466-471, 2000. 296. Human GnRH-secreting cultured neurons express activin ßA subunit mRNA and secrete dimeric activin A. Florio P, Vannelli G, Luisi S, Berni T, Zonefrati R, Falaschi C, Bifulco G, Genazzani AR, Petraglia F. Eur. J. Endo., 143: 133-138, 2000. 297. Influence of non-gonadotrophic hormones on gonadal function. Pezzani I, Reis FM, Di Leonardo C, Luisi S, Santuz M, Driul , Cobellis L, Petraglia F. Mol. Cell. Endo., 161: 37-42, 2000.


49

298. Second trimester levels of maternal serum inhibin A and human chorionic gonadotropin predict preeclampsia in the third trimester of pregnancy. Lambert-Messerlian G, Silver H, Petraglia F, Luisi S, Pezzani I, Maybruck W, Allen Hogge W, Hanley-Yanez K, Roberts JM, Neveux LM, Canick JA. J. Soc. Gynecol. Invest., 7: 170-174, 2000. 299 Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery and in hypertensive patients. Luisi S, Petraglia F, Benedetto C, Nappi RE, Bernardi F, Fadalti M, Reis FM, Luisi M, Genazzani AR. J. Clin. Endocrinol. Metab., 85: 2429-2433, 2000. 300. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. Pirisi M, Fabris C, Luisi S, Santuz M, Toniutto P, Vitulli D, Federico E, Del Forno M, Mattiuzzo M, Branca B, Petraglia F. Cancer Detection and Prevention, 24: 150-155, 2000. 301. Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A. Fertility and Sterility, 74: 809-812, 2000. 302. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea. Genazzani AD, Stomati M, Bersi C, Luisi S, Fedalti M, Santuz M, Esposito G, Petraglia F, Genazzani AR. Journal of Endocrinological Investigation 23: 526-532, 2000. 303. The use of combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycycstic ovary disease after discontinuation of treatment. Genazzani AD, Battaglia C, Gamba O, Petraglia F, Malavasi B, Genazzani AR. Journal of Assisted Reproduction and Genetics, 17, 269-275, 2000. 304. Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Genazzani AR, Bernardi F, Stomati M, Monteleone P, Luisi S, Rubino S, Farzati A, Casarosa E, Luisi M, Petraglia F. Neuroendocrinology 72: 162-170, 2000. 305. Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations. Plaino L, Stomati M, Casarosa E, Artini PG, Santuz M, D’Ambrogio G, Cobellis L, Luisi M, Genazzani AR, Petraglia F. Gynecological Endocrinology, 14: 231-235, 2000.


50

306. Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome. De Leo V, La Marca A, Morgante G, Ciotta L, Mencaglia L, Cianci A, Petraglia F. Human Reproduction, 15: 2302-2305, 2000. 307. Mechanisms responsible for endothetial dysfunction associated with acute estrogen deprivation in normotensive women. Virdis A, Ghiadoni L, Pinto S, Lombardo M, Petraglia F, Genazzani A, Buralli S, Taddei S, Salvetti A. Circulation, 101 (19): 2258-2263, 2000. 308. High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: relationship with oestradiol and nitric oxide metabolites. Reis MF, Faletti A, Luisi S, Bifulco G, Cauci S, Quadrifoglio F, Dor J, Petraglia F. Molecular Human Reproduction, 6 (12): 1079-1083, 2000. 309. The use of a starting dose recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study. Battaglia C, Regnani G, Petraglia F, Genazzani AR; Artini PG, Volpe A. Gynecological Endocrinology, 14: 311-315, 2000. 310. Paracrine/autocrine control of female reproduction. Rei F, Cobellis L, Luisi S, Driul L, Florio P, Faletti A, Petraglia F. Gynecological Endocrinology, 14: 464-475, 2000. 311. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. De Leo V, La Marca A, Morgante G, Lanzetta D, Setacci C, Petraglia F. American J Obstet Gynecol, 184: 350-353, 2001. 312. Evidence for local production of inhibin A and activin A in ovarian endometriosis. Reis FM, Di Blasio AM, Florio P, Ambrosini G, Di Loreto C, Petraglia F. Fertility and Sterility, 75 (2): 367-373, 2001 313. Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata. De Leo V, La Marca A, Morgante G, Severi FM, Petraglia F. Fertility and Sterility, 75 (3): 632-633, 2001. 314. Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels. Bondanelli M, Margutti A, Ambrosio MR, Plaino D, Cobellis L, Petraglia F, Degli Uberti EC. Journal of Clinical Endocrinology and Metabolism, 2001, in press.


51

315. Serum allopregnanolone in women with postpartum “blues”. Nappi RE, Petraglia F, Luisi S, Polatti F, Farina C, Genazzani AR. Obstetrics and Gynecology, 97 (1): 77-80, 2001. 316. Human placenta a a source of neuroendocrine factors. Reis F, Florio P, Cobellis L, Luisi S, Severi FM, Bocchi C, Picciolini E, Centini G, Petraglia F. Biology of the neonate, 79: 150-156, 2001. 317. Maternal plasma calcitonin gene-related peptide levels do not change during labor and are not influenced by delivery route. Florio P, Margutti A, Apa R, Miceli F, Pezzani I, Degli Uberti EC, Petraglia F. J. Soc. Gynecol Investig, 2001, in press. 318. Serum activin A levels in males and females during pubertal development. Luisi S, Lombardi I, Florio P, Cobellis L, Iughetti L, Bernasconi S, Genazzani AR, Petraglia F. Gynecological Endocrinology, 15: 1-4, 2001. 319. Ultrasound diagnosis and Doppler monitoring of a pelvic spleen in pregnancy. Cobellis L, Di Pietto F, Di Pietto L, Stradella L, Reis FM, Severi FM, Petraglia F. Ultrasound Obstet Gynecol, 17: 453-454, 2001. 320. Changes in inhibins and activin secretion in healthy and pathological pregnancies. Florio P, Cobellis L, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F. Molecular and Cellular Endocrinology, 180: 123-130, 2001. 321. Updating the role of radiotherapy in the management of epithelial ovarian cancer. Pirtoli L, Rubino G, Danero S, Cobellis L, Petraglia F. Italian Journal of Gynaecology and Obstetrics, 2: 52-60, 2001. 322. Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. De Leo V, La Marca A, Morgante G, Lanzetta D, Florio P, Petraglia F. Maturitas, 39: 185-188, 2001. 323. Expression and secretion of activin A: possible physiological and clinical implications. Luisi S, Florio P, Reis F, Petraglia F. European Journal of Endocrinology, 145: 225-236, 2001. 324. Clinical implications of circulating neurosteroids. Genazzani AR, Monteleone P, Stomati M, Bernardi F, Cobellis L, Casarosa E, Luisi M, Petraglia F. Neurobiology, in press 325. Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea. Genazzani AD, Bersi C, Luisi S, Fruzzetti F, Malavasi B, Luisi M, Petraglia F, Genazzani AR.


52

The Journal of Steroid Biochemistry & Molecular Biology, in press. 326. Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea. Genazzani AD, Strucchi C, Malavasi B, Tortolani F, Vecchi F, Luisi S, Petraglia F. Gynecol Endocrinol, 15: 279-285, 2001. 327. Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives. De Leo V, La Marca A, Morgante G, Lucani B, Nami R, Ciotta L, Cianci A, Petraglia F. Contraception, 64: 145-148, 2001. 328. From biology to biocheical and biophysical diagnostic tools of ovarian tumors. Cobellis L, Severi FM, Petraglia F. Current Problems in Obstetrics, Gynecology and Fertility, 24: 153-196, 2001. 329. Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks’ gestation. Petraglia F, Hatch MC, Lapinski R, Stomati M, reis FM, Cobellis L, Berkowitz GS. Journal Soc Gynecol Investig, 8: 83-88, 2001. 330. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits. Cobellis L, Cataldi P, Reis F, De Palo G, Raspagliesi F, Pilotti S, Arcuri F, Petraglia F. European Journal of Endocrinology, 145: 779-784, 2001. 331. Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women. Florio P, Quirici B, Casarosa E, Lombardi I, Luisi M, Genazzani AD, Petraglia F, Genazzani AR. Gynecol Endocrinol, 15: 359-366, 2001. 332. Cyclooxygenase-2 immunoreactivity in the ischemic neonatal human brain. An autopsy study. Toti P, De Felice C, Schürfeld, Stumpo M, Bartolomei S, Lombardi A, Petraglia F, Buonocore G. J. Submicrosc. Cytol. Pathol., 33(3): 245-249, 2001. 333. Human placental corticotropin-releasing factor (CRF) in the adaptive response to pregnancy. Florio P, Petraglia F. Stress, 4: 247-261, 2001. 334. Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climateric women. Morgante G, La Marca A, Ditto A, Musacchio MC, Cavicchioli C, Lanzetta D, Petraglia F, De leo V. Gynecological Endocrinology, 5: 466-471, 2001. 335. Regression of ovarian enlargement in pharmacological ovulation induction. Cobellis L, Pecori E, De Lucia E, Pierno G, Stradella L, Severi FM, Petraglia F. Gynecological Endocrinology, 15 (3): 239-242, 2001.


53

336. Increased response of plasma allopregnanolone to corticotropin-releasinf hormone in obese patients. Menozzi R, Florio P, Bondi M, Luisi S, Cobellis L, Genazzani AR, Del Rio G, Petraglia F. Neuroendocrinology, 75: 124-129, 2002. 337. Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid during the menstrual cycle and in amenorrheic subjects. Genazzani AD, Luisi M, Malavasi B, Strucchi C, Luisi S, Casarosa E, Bernardi F, Genazzani R, Petraglia F. European Journal of Endocrinology, 146: 347-356, 2002. 338. High levels of human chromogranin A in umbilical cord plasma and amniotic fluid at parturition. Florio P, Mezzesimi A, Turchetti V, Severi FM, Ticconi C, Forconi S, Petraglia F. Journal of the Society for Ginecologic Investigation, 9:32-36, 2002. 339. Estrogen receptor α mRNA variant lacking exon 5 in co-expressed with the wild-type in endometrial adenocarcinoma. Cobellis L, Reis FM, Driul L, Vultaggio G, Ferretti I, Villa E, Petraglia F. European Journal of Obstetrics & Gynecology and Reproductive Biology, 102: 92-95, 2002. 340. Serum inhibin A, inhibin B, and pro-αC levels are altered after surgically or pharmacologically induced menopause. Cobellis L, Luisi S, Pezzani I, Reis FM, De Leo V, Petraglia F. Fertility and Sterility, 77: 745-749, 2002. 341. Electro-cautery of myomas during caesarean section – two cases reports. Cobellis L, Florio P, Stradella L, De Lucia E, Messalli EM, Petraglia F, Cobellis G. European Journal of Obstetrics & Gynecology and Reproductive Biology, 102: 98-99, 2002. 342. Reduction of steps in the preparation of motile sperm for intrauterine insemination does not reduce efficacy of the procedure: simplified one-step swim-up method versus classic swim-up. Inaudi P, Petrilli S, Joghtapour A, Trusso P, Petraglia F. Human Reproduction, 17: 1288-1291, 2002. 343. Identification of urocortin mRNA and peptide in the human endometrium. Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia F. Journal of Endocrinology, 173: R9-R14, 2002. 344. Serum and tissue expression of activin A in postmenopausal women with breast cancer. Reis FM, Cobellis L, Tameirăo LC, Anania G, Luisi S, Silva ISB, Gioffrè W, Di Blasio AM, Petraglia F. The Journal of Clinical Endocrinology and Metabolism, 87: 2277-2282, 2002. 345. High serum allopregnanolone levels in girls with precocious puberty. Iughetti L, Predieri B, Cobellis L, Luisi S, Luisi M, Forese S, Petraglia F, Bernasconi S.


54

The Journal of Clinical Endocrinology and Metabolism, 87: 2262-2265, 2002. 346. Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Reis FM, D’Antona D, Petraglia F. Endocrine Review, 23: 230-257, 2002. 347. Expression of prolacrin-releasing peptide and its receptor in the human decidua. Reis FM, Viganò P, Arnaboldi E, Spritzer PM, Petraglia F, Di Blasio AM. Molecular Human Reproduction, 8: 356-362, 2002. 348. Serum activin A and inhibin A. New clinical markers for hydatidiform mole. Florio P, Severi FM, Cobellis L, Danero S, Bomè A, Luisi S, Petraglia F. Cancer, 94: 2618-2622, 2002. 349. Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women. Setacci C, La Marca A, Agricola E, Morgante G, Setacci F, Cappelli A, Petraglia F, De Leo V. American Journal of Obstetrics & Gynecology, 186: 832-835, 2002. 350. Levels of maternal plasma corticotopin-releasing factor and urocortin during labor. Florio P, Cobellis L, Woodman J, Severi FM, Linton EA, Petraglia F. Journal of Society for Gynecological Investigation, 9: 233-237, 2002. 351. Small thymus at birth: a predictive radiographic sign of bronchopulmonary dysplasia. De Felice C, Latini G, Del Vecchio A, Toti P, Bagnoli F, Petraglia F. Pediatrics, 110: 386-388, 2002. 352. The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism. Morgante G, La Marca A, Setacci F, Setacci C, Petraglia F, De Leo V. Gynecologic and Obstetrics Investigation, 53: 200-203, 2002. 353. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma. Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Del Vecchio MT. The Prostate, 52: 167-172, 2002. 354. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. Baccetti B, La Marca A, Piomboni P, Capitani S, Bruni E, Petraglia F, De Leo V. Human Reproduction, 17: 2673-2677, 2002. 355. A benefit-risk assessment of medical treatment for uterine leiomyomas.


55

De Leo V, Morgante G, La Marca A, Musacchio MC, Sorace M, Cavicchioli C, Petraglia F. Drug Safety, 25: 759-779, 2002. 356. Polyhydramnios: a predictor of severe growth impairment in achondroplasia. Latini G, De Felice C, Parrini S, Verrotti A, Di Maggio G, Petraglia F. The Journal of Pediatrics, 141: 274-276, 2002. 357. Corticotropin-releasing factor, urocortin and endothelin-1 stimulate activin A release from cultured human placental cells. Reis FM, Luisi S, Florio P, Degrassi A, PetragliaF. Placenta, 23: 522-525, 2002. 358. Mechanism of increased maternal serum total activin A and inhibin A in preeclampsia. Silver HM, Lambert-Messerlian GM, Reis FM, Di Blasio AM, Petraglia F, Canick JA. Journal of the Society for Gynecologic Investigation, 9: 308-312, 2002. 359. Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert-Messerlian G, Severi FM, Petraglia F. Gynecological Endocrinology, 16: 365-372, 2002. 360. Ovarian hyperstimulation-like sindrome after administration of triptorelin to a woman with endometriosis. Inaudi P, Mazzini M, D’Aniello G, Trusso P, Joghtapour A, Petraglia F. Gynecological Endocrinology, 16: 403-405, 2002. 361. Identification of activin A and follistatin in human milk. Luisi S, Calonaci G, Florio P, Lombardi I, De Felice C, Bagnoli F, Petraglia F. Growth Factors, 20: 147-150, 2002. 362. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. La Marca A, Morgante G, Palumbo M, Cianci A, Petraglia F, De Leo V. Fertility and Sterility, 78: 1234-1239, 2002. 363. Reversible increase of serum activin A levels in women with Graves’ disease. Centanni M, Viceconti N, Luisi S, Reis FM, Gargano L, Maiani F, Franchi A, Canettieri G, Petraglia F. Journal of Society for Gynecological Investigation, 25: 967-970, 2002. 364. Increased serum inhibin B levels in postmenopausal women with altered thyroid function Viceconti N., Luisi S., Nardo S., Gargano L., Franchi a.; Sibilla R., Canettieri G., Petraglia F., Centanni M. Horm Metab Res 2003; 35: 498-501 365. Abruptio placentae and highest maternal serum activin A levels at mid-gestation: a two case report. Florio P, Severi FM, Bocchi C, Luisi S, Petraglia F.


56

Placenta, 24: 279-280, 2003. 366. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Luisi S, Florio P, D’Antona D, Severi FM, Sanseverino F, Danero S, Petraglia F. European Journal of Endocrinology, 148: 233-236, 2003. 367. The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia. Florio P, Reis FM, Pezzani I, Luisi S, Severi FM, Petraglia F. Ultrasound Obstetrics Gynecology, 21:165-169, 2003. 368. Prenatal diagnosis of esophageal atresia with the pouch sign. Centini G, Rosignoli L, Kenanidis A, Petraglia F. Ultrasound Obstetrics and Gynecology, 21: 494-497, 2003.. 369. Ovarian psammocarcinoma with peritoneal implants. Cobellis L, Pezzani I, Cataldi P, Bomè A, Santopietro R, Petraglia F. European Journal of Obstetrics & Gynecology and Reproductive Biology, 107: 217-219, 2003. 370. Transvaginal ultrasonography in women receiving emergency contraception. Severi FM, Bocchi C, Florio P, Cobellis L, Ignacchiti E, Petraglia F. Fertility and Sterility, 79: 1074-1077, 2003. 371. Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children. Grosso S, Luisi S, Mostardini R, Farnetani M, Cobellis L, Morgese G, Balestri P, Petraglia F. Epilepsy Research, 54: 29-34, 2003. 372. Serum inhibin B correlates with successful ovulation in infertile women. Luisi S, Palumbo M, Calonaci G, De Leo V, Razzi S, Inaudi P, Cobellis G, Petraglia F. Journal of Assisted Reproduction and Genetics, 20: 241-247, 2003. 373. High plasma concentrations of di- 2-(ethylhexyl)-phthalate in women with endometriosis. Cobellis L, Latini G, De Felice C, Razzi S, Paris I, Ruggieri F, Mazzeo P, Petraglia F. Human Reproduction, 18: 1512-1515, 2003. 374. Inhibin A, inhibin B and activin A concentrations in umbilical cord artery and vein. Florio P, Calonaci G, Luisi S, Severi FM, Ignacchiti E, Palumbo M, Bocchi C, Petraglia F. Gynecological Endocrinology, 17: 181-185, 2003. 375. A report of early (13+0 to 14+6 weeks) and mid-trimester amniocenteses: 10 years’ experience. Centini G, Rosignoli L, Kenanidis A, Scarinci R, Petraglia F. The Journal of Maternal-Fetal and Neonatal Medicine,14: 113-117, 2003.


57

376. Combination of statins and hormone replacement therapy in postmenopausal women is associated with increased bone mineral density. De Leo V, Morgante G, La Marca A, Lanzetta D, Cobellis L, Petraglia F. Gynecological Endocrinology, 17: 329-332, 2003. 377. Human placenta and fetal membranes express follistatin-related gene mRNA and protein. Ciarmela P, Florio P, Toti P, Franchini A, Maguer-Satta V, Ginanneschi C, Ottaviani E, Petraglia F. J. Endocrinol. Invest., 26: 641-645, 2003. 378. Comparison of two dimensional and three-dimensional ultrasound in the assessment of the cervix to predict preterm delivery. Severi FM, Bocchi C, Florio P, Picciolini E, D’Aniello G, Petraglia F. Ultrasound in Med. & Biol., 29: 1261-1265, 2003. 379. Insulin. Lowering Agents in the Management of Policystic Ovary Syndrome. De Leo V, La Marca A, Petraglia F. Endocrine Reviews, 24(5): 633-667, 2003. 380. Higt Levels of Intrauterine Corticotrophin-Releasing Hormone, Urocortin, Tryptase, and Interleukin-8 in Spontaneous Abortions. Florio P, Ciarmela P, Arcuri F, Petraglia F. The Journal of Clinica Endocrinology & Metabolism, 88(11): 5580-5581, 2003. 381. The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome. D’Aniello G, Florio P, Sabatini L, Severi F. M, Fineschi D, Cito G, Guidoni C. G, Petraglia F. Journal of Hipertension, 21: 1915-1920, 2003. 382. Abnormnal umbilicar artery doppler waveforms and cord blood Iinhibin A and Inhibin B levels. Florio P, Severi F. M, Luisi S, Ignacchiti E, Calonaci G, Bocchi C, Petraglia F. Biology of the Neonate, 84: 281-286, 2003. 383. Role of the Retinoblastoma Family in Gynecological Cancer. Sanseverino F, Torricelli M, Petraglia F, Giordano A. Cancer Biology & Therapy 2: 6, e30-e35, 2003. 384. Paracrine regulation of endometrial function: interaction between progesterone and corticotropin–releasing factor (CRF) and activin A Florio P, Rossi M, Sigurdardottir M, Ciarmela P, Luisi S, Viganò P, Grasso D, Fiore G, Cobellis L, Di Blasio AM, Petraglia F. Steroids 68: 801-807, 2003 385. Expression of betaglycan in pregnant tissues throughout gestation Ciarmela P, Florio P, Toti P, Grasso D, Santopietro R, Tosi P, Petraglia F. European Journal of Endocrinology, 149: 433-437, 2003


58

386. Prediction of successful induction of labor at term: role of clinical history, digital examination, ultrasound assessment of the cervix and fetal fibronectin assay. Reis FM, Gervasi MT, Florio P, Bracalente G, Fadalti M, Severi FM, Petraglia F. American Journal Obstetrics Gynecology, 189(5):1361-1367, 2003 387. Endometrial expression and secretion of activin A, bt not follistatin, increase in the secretori phase of the menstrual cycle. Florio P, Severi F.M, Luisi S, Ciarmela P, Calonaci G, Cobellis L, Petraglia F. J Soc. Gynecol Investig. 10 (4): 237-243, 2003 388. Prenatal ultrasonographic diagnosis of diastrophic dysplasia at 13 weeks of gestation. Severi FM, Bocchi C, Sanseverino F, Petraglia F. J Matern Fetal Neonatal Med. 13(4):282-284, 2003

389. Cervical ripening and induction of labor by prostaglandin E2: a comparison between intracervical gel and vaginal pessary D’Aniello g, Bocchi C, Florio P, Ignacchiti E, Guidoni GC, Centini G, Cito G, Picciolini E, Severi FM, Petraglia F. J Matern Fetal Neonatal Med. 14 (3): 158-162, 2003

390. Impaired uterine artery blood flow at mid gestation anl low levels of maternal plasma corticotropin releasing factor. Florio P, Severi FM, Fiore G, Micheli L, Bocchi C, Nencini C, Pezzani I, Giorgi G, Petraglia F. J Soc. Gynecol Investig. 10 (5): 294-297, 2003

391. Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: Relationsip to estrogen and progesterone receptor status. Cioppi F, Simi L, Luciani P, Petraglia F, Susini T, Cobellis L, Serio M, Maggi M, Peri A. Oncology Reports, 11: 427-433, 2004 392. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised woman. Razzi S, Fava A, Sartini A, De Simone S, Cobellis L, Petraglia F. BJOG: an International Journal of Obstetrics and Gynecology, 111: 182-184, 2004 393. Voluminous perinatal pelvic mass: a case of congenital Hydrometrocolpos Messina M, Severi F.M, Bocchi C, Ferrucci E, Di Maggio G, Petraglia F. The Journal of Maternal_Fetal and Neonatal Medicine, 15: 135-137, 2004 394. Umbilical endometriosis in pregnancy: a case report Razzi S, Rubegni P, Sartini A, De Simone S, Fava A, Cobellis L, Fimiani M, Petraglia F. Gynecological Endocrinology, 18: 114-116, 2004


59

395. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome. Lombardi I, Luisi S, Quirici B, Monteleone P, Bernardi F, Liut M, Casarosa E, Palumbo M, Petraglia F, Genazzani A.R. Gynecological Endocrinology, 18: 79-87, 2004. 396. Activin A: A possible Marker for liver Transplant Outcome Luisi S, Donini A, Gioffrè W, Baccarani U, Petraglia F. Growth Factors, 22 (1): 61-62, 2004 397. Human endometrium and decidua express follistatin-related gene (FLRG) mRNA and peptide Florio P, Ciarmela P, Toti P, Maguer-Satta V, Rimokh R, Buonocore G, Rossi M, Gioffrè W, Petraglia F. Molecular and cellular Endocrinology, 218: 129-135, 2004 398. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis Cobellis L, Razzi S, Fava A, Severi FM, Igarashi M, Petraglia F. Fertil Steril, 82(1):239-240, 2004 399. Panic disorder in menopause: a case control study Pacchierotti C, Castrogiovanni A, Cavicchioli C, Luisi S, Morgante G, De Leo V, Petraglia F, Castrogiovanni P. Maturitas, 48: 147-154, 2004 400. Amniotic Fluid S100B protein in mid gestation and intrauterine fetal death Florio P, Michetti F, Bruschettini M, Lituania M, Bruschettini P, Severi FM, Petraglia F, Gazzolo D. Lancet, 364: 270-272, 2004 401. The FeTouch Project: an application of haptic technologies to obstetrics and gynaecology Prattichizzo D, La torre P, Barbagli F, Vicino A, Severi FM, Petraglia F. Int. J. Medical Robotics and Computer Assisted Surgery, 1 (1): 1-5, 2004 402. Pregnancy and Delivery After Right Common Carotid Artery Endarterectomy Severi FM, Ignacchiti E, Setacci F, Palasciano G, Setacci C, Petraglia F. Obstet. Gynecol., 104 (5):1140-1142, 2004 403. The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-Binding Protein improves the early prediction of preeclampsia Florio P, Imperatore A, Sanseverino F, Torricelli M, Reis FM, Lowry PJ, Petraglia F. The Journal of clinical Endocrinology & Metabolism, 89 (9): 4673-4677, 2004


60

404. The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis Cobellis L, Razzi S, De Simone S, Sartini A, Fava A, Danero S, Gioffrè W, Mazzini M, Petraglia F. Eur J Obstet Gynecol Reprod Biol 116 (1): 100-102, 2004 405. Urocortins in human reproduction Florio P, Vale W, Petraglia F. Peptides, 25(10): 1751,1757,2004 406. Inhibin and activins in pregnancy. Florio P, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F. Mol. Cell Endocrinol, 225 (1-2): 93-100, 2004 407. Activin, inhibin and the human breast Reis FM, Luisi S, Carniero MM, Cobellis L, Federico M, Camargos AF, Petraglia F. Mol. Cell Endocrinol, 225 (1-2): 77-82, 2004 408. Follistatin-related gene expression, but not follistatin expression, is decreased in human endometrial adenocarcinoma. Ciarmela P, Florio P, Siguardottir M, Toti P, Maguer sSatta V, Rimokh R, Altomare A, Tosi P, Petraglia F. Eur J Endocrinol, 151 (2): 251-257, 2004 409. High concentrations of activin A in the peritoneal fluid of women with epithelial ovarian cancer Cobellis L, Reis F M, Luisi S, Danero S, Pirtoli L, Scambia G, Petraglia F. Journal of the Society for Gynecologic Investigation, 11: 203-206, 2004 410. Menopause the cardiovascular risk factor homocysteine and the effects of treatment De Leo V, La Marca A, Morgante G, Musacchio C, Luisi S, Petraglia F. Treat Endocrinol, 3(6): 393-400, 2004 411. Factor II:C activity and uterine artery Doppler evaluation to improve the early prediction of pre-eclampsia on women with gestational hypertension Florio P., D’Aniello G., Sabatini L., Severi F.M., Fineschi D., Bocchi C., Reis F.M., Petraglia F. Journal of Hypertension, Vol. 22, 1 – 6, 2004 412. Cerebrospinal Fluid Activin A Measurement in Asphyxiated Full-Term Newborns Predicts Hypoxic Ischemic Encephalopathy Florio P., Luisi S., Bruschettini M., Grutzfeld D., Dobrzanska A., Bruschettini P., Petraglia F., Gazzolo D. Clinical Chemistry 50, No. 12, 2004 413. Blink-startle reflex habituation in 30-34- week low-risk fetuses Bellieni C.V., Severi F.M., Bocchi C., Caparelli N., Bagnoli F., Buonocore G.,Petraglia F. J.Perinatal.Med.33: 33-37,2005


61

414. Mutational analysis of the inhibin alpha gene in preeclamptic women Ciarmela P., Florio P., Battistini S., Grasso D., Amato T., Boschi S., Marozio L., Benedetto C., Petraglia F. Journal of Endocrinology Investigation, Vol. 28, 30 – 33, 2005 415. Factor II: C activity and uterine artery Doppler evaluation to improve the early prediction of pre-eclampsia on women with gestational hypertension Florio P, D’Aniello G, Sabatini L, Severi FM, Fineschi D, Bocchi C, Reis FM, Petraglia F. J Hypertension 2005 Jan; 23 (1): 141-6 416. Virtual fetal touch through a haptic interface decreases maternal anxiety and salivary cortisol Severi FM, Prattichizzo D, Casarosa E, Barbagli F, Ferretti C, Altomare A, Vicino A, Petraglia F. Journal Soc Gynecol Investig. 2005 Jan; 12 (1): 37-40 417. Post-ictal circulating levels of allopregnanolone in children with partial or generalized seizures GrossoS., Luisi S., Berardi R., Mostardini R., Cordelli D.M., Morgese G., Petraglia F., Balestri P. Epilepsy Research, Vol. 63, 97 – 102, 2005 418. Inhibin alpha-subunit and the inhibin coreceptor betaglycan are downregulated in endometrial carcinoma Florio P., Ciarmela P., Reis F.M., Toti P., Galleri L., Santopietro R., Tiso E., Tosi P., Petraglia F. European Journal of Endocrinology, Vol. 152, 277 – 284, 2005 419. Maternal position during non-stress test and fetal heart rate patterns Cito G., Luisi S., Mezzesimi A., Cavicchioli C., Calonaci G., Petraglia F. Acta Obstetricia et Gynecologica Scandinavica, Vol. 84, pp. 335-338, 2005 420. Re-evaluation of risk for Down syndrome by means of the combined test in pregnant women of 35 years or more Centini G., Rosignoli L., Scarinci R., Faldini E., Morra C., Centini GA., Petraglia F. Prenatal Diagnosis, Vol. 25, pp. 133-136, 2005 421. Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy Florio P., Calonaci G., Severi F.M., Torricelli M., Bocchi C., Fiore G., Linton E.A., Petraglia F. Journal of the Society for Gynecologic Investigation, 12: 191-194, 2005 422. Inhibins in female and male reproductive physiology: role in gametogenesis, conception, implantation and early pregnancy Luisi S., Florio P., Reis F.M., Petraglia F. Human Reproduction Update, Vol. 11, No. 2, pp. 123 – 135, 2005 423. Placental Expression of Substance P and Vasoactive Intestinal Peptide: Evidence for a Local Effect on Hormone Release. Marzioni D., Fiore G., Giordano A., Nabissi M., Florio P., Verdenelli F., Petraglia F., Castellucci M.


62

The Journal of Clinical Endocrinology & Metabolism 90 (3), pp. 1 – 6, 2005 424. Yolk sac tumor in a young girl: A case report Razzi S., Luisi S., Gabbanini M., Lazzeri L., Mazzini M., Petraglia F. Gynecological Endocrinology, 20 (6): 334-335, 2005 425. Isoprostanes in amniotic fluid: A predictive marker for fetal growth restriction in pregnancy Longini M, Perrone S, Kenanidis A, Vezzosi P, Marzocchi B, Petraglia F, Centini G, Buonocore G. Free Radical Biology & Medicine, Vol. 1, 1537 – 1541, 2005 426. Molecular Pathology of Ovarian Cancer Sanseverino F., D’Andrilli G., Petraglia F., Giordano A. Anal Quant Cytol Histol., 2005 Jun; 27(3): 121 - 4 427. Endothelin-1 Triggers Placental Oxidative Stress Pathways: Putative Role in Preeclampsia Fiore G., Florio P., Micheli L., Nencini C., Rossi M., Cerretani D., Ambrosini G., Giorgi G., Petraglia F. The Journal of Clinical Endocrinology and Metabolism, Vol. 90 (7), 4205 –4210, 2005 428. Other uses of homologous skin grafts and skin bank bioproducts Figiani M, Pianigiani E, Cherubini Di Simplicio F, Sbano P, Cuccia A, Pompella G, De Aloe G, Petraglia F. Clinics in Dermatology, Vol. 23, 396-402, 2005 429. Is an excessive number of prenatal ochographies a risk for fetal growth? Bellieni C.V., Buonocore G., Bagnoli F., Cordelli D.M., Gasparre O., Calonaci F., Filardi G., Merola A., Petraglia F. Early Human Development (2005), 81, 689 – 693 430. Low serum allopregnanolone levels in girls with precocious pubarche Iughetti L., Predieri B., Luisi S., Casarosa E., Bernasconi S., Petraglia F. Steroids,70 (2005), 725 - 731 431. High Fetal Urocortin Levels at Term and Preterm Labor Florio P., Torricelli M., Galleri L., De Falco G., Leucci, E., Calonaci G., Picciolini E., Ambrosini G., Linton E. A., Petraglia F. The Journal of Clinical Endocrinology and Metabolism; 90(9):5361-5365, 2005 432. Feto – maternal biology and ethics of human society Paulesu L., Ietta F., Petraglia F. Reproductive Biology and Endocrinology; 3:55, 2005 433. The significance of screening tests for aneuploidies in populations at low and high maternal-age-related risk. Centini G, Rosignoli L, Scarinci R, Pasqui L, Talluri B, Kenanidis A, Faldini E, Cazzavacca R, Petraglia F.


63

Minerva Ginecologica; 57(5): 557-61, 2005 434. Identification of genes regulated by Interleukin - 1β in human endometrial stromal cells Rossi M., Sharkey A.M., Viganò P., Fiore G., Furlong R., Florio P., Ambrosini G., Smith S. K., Petraglia F. Reproduction; 130(5):721-729, 2005 435. Listeriosis in pregnancy: A case report Cito. G., Luisi S., Faldini E., Calonaci G., Sanseverino F., Torricelli M., Petraglia F. The Journal of Maternal-Fetal and Neonatal Medicine; 18(6); 367-8, 2005 436. Effect of activin A on tumor necrosis factor-alpha/intercellular adhesion molecule- 1 pathway in endometrial stromal cells Mangioni S., Viganò P., Florio P., Borghi O., Vignali M., Petraglia F., Di Blasio A.M. European Juornal of Obstetrics & Gynecology and Reproductive Biology; 123(2): 218-23, 2005

437. pRb2/p130 and VEGF Expression in Endometrial Carcinoma in Relation to Angiogenesis and Histopathologic Tumor Grade. Sanseverino F., Santopietro R., Torricelli M., D’Andrilli G., Russo G., Cevenini G., Bovicelli A., Leoncini L., Scambia G., Petraglia F., Claudio P.P., Giordano A. Cancer Biology and Therapy; 5(1): 84-8, 2006 438. Low serum concentrations of di-(2-ethylhexyl) phthalate in women with uterine fibromatosis Luisi S., Latini G., De Felice C., Sanseverino F., Di Pasquale D., Mazzeo P., Petraglia F. Gynecological Endocrinology; 22(2): 92-5, 2006 439. Maternal plasma corticotrophin – releasing factor and urocortin levels in post-term pregnancies Torricelli M., Ignacchiti E., Giovannelli A., Merola A., Scarpetti E., Calonaci G., Picciolini E., Florio P., Reis F.M., Linton E.A., Petraglia F. European Journal of Endocrinology; 154(2):281-5, 2006 440. Estrogen receptor gene polymorphisms are associated with recurrence of endometriosis Luisi S., Galleri L., Marini F., Ambrosini G., Brandi M.L., Petraglia F. Fertility and Sterility; 85(3): 764-6, 2006 441. Umbilical Cord Serum Activin A Levels are Increased in Pre-eclampsia with Imparied Blood Flow in the Uteroplacental and Fetal Circulation Florio P., Reis F. M., Severi F.M., Luisi S., Imperatore A., Palumbo M. A., Bagnoli F., Gioffrè W., Petraglia F. Placenta; 27(4-5): 432-7, 2006 442. Human placenta and fetal membranes express nerve growth factor mRNA and protein. Toti P., Ciarmela P., Florio P., Volpi N., Occhini R., Petraglia F. Journal of Endocrinological Investigation; 29(4):337-41, 2006


64

443. Surgical scar endometriosis after Cesarean section: A case report Luisi S., Gabbanini M., Sollazzi S., Calonaci F., Razzi S., Petraglia F. Gynecological Endocrinology; 22(5): 284-285, 2006 444. High Maternal Blood S100B Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and Intraventricular Hemorrhage Gazzolo D., Marinoni E., Di Iorio R., Lituania M., Marras M., Bruschettini M., Bruschettini P., Frulio R., Michetti F., Petraglia F., Florio P. Clinical Chemistry; 52(5):819-26, 2006 445. Corticotropin-releasing hormone, its binding protein and receptors in human cervical tissue at preterm and term labor in comparison to non-pregnant state Klimaviciute A., Calciolari J., Bertucci E., Abelin-Tornblöm S.,Stjernholm-Vladic Y., Byström B., Petraglia F., Ekman-Ordeberg G. Reproductive Biology and Endocrinology; 4:29, 2006 446. Effectiveness of oral administration of Lactobacillus paracasei subsp. Paracasei F19 in association with vaginal suppositories of Lactobacillus acidofilus in the treatment of vaginosis and in the prevention of recurrent vaginitis. Delia A, Morgante G, Rago G, Musacchio MC, Petraglia F, De Leo V. Minerva Ginecologica; 58(3):227-31, 2006 447. The effects of HIV 1 Tat Protein on cell cycle during cervical carcinogenesis Nyagol J., Leucci E., Onnis A., De Falco G., Tigli C., Sanseverino F., Torricelli M., Palammo N., Pacenti L., Santopietro R., Spina D., Gichangi P., Muchiri L., Lazzi S., Petraglia F., Leoncini L., Giordano A.. Cancer Biology & Therapy; 5(6): 684-90, 2006 448. Urocortin expression is downregulated in human endometrial carcinoma. Florio P, De Falco G, Leucci E, Torricelli M, Torres PB, Toti P, Dell’Anna A, Tiso E, Santopietro R,,Leoncini L, Petraglia F. Journal of Endocrinology; 190(1):99-105, 2006 449. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women. Morgante G, Delia A, Musacchio MC,Severi FM, Petraglia F, De Leo V Gynecogical Endocrinology;22(7):376-80, 2006 450. Urocortin 2 and urocortin 3 are expressed by the human placenta, diciduas and fetal membranes Imperatore A., Florio P., Torres P.B., Torricelli M., Galleri L., Toti P., Occhini R., Picciolini E., Vale W., Petraglia F. American Journal of Obstetrics and Gynecology; 195 (1):288-95, 2006


65

451. Increased plasma concentrations of Activin A predict intraventricular hemorrhage in preterm newborns Florio P., Perrone S., Luisi S., Vezzosi P., Longini M., Marzocchi B., Petraglia F., Buonocore G. Clinical Chemistry; 52(8):1516-21, 2006 452. Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension Torricelli M, Reis FM, Florio P, Severi FM, Bocchi C, Picciolini E, Guidoni CG, Petraglia F. Ultrasound in Medicine and Biology; 32 (9):1431-5, 2006 453. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Florio P, Marinoni E, Di Iorio R, Bashir M,Ciotti S,Sacchi R, Bruschettini M,Lituania M, Serra G, Michetti F,Petraglia F, Gazzolo D. Pediatrics; 118(3):747-54, 2006 454. High maternal and fetal plasma urocortin levels in pregnancies complicated by hypertension. Florio P,Torricelli M,De Falco G, Leucci E,Giovannelli A, Gazzolo D,Severi FM, Bagnoli F,Leoncini L,Linton EA,Petraglia F. Journal of Hypertension; 24(9):1831-40, 2006 455. Metformin treatment is effective in obese teenage girls with PCOS De Leo V., Musacchio M.C., Morgante G., Piomboni P., Petraglia F. Human Reproduction; 21(9):2252-6, 2006 456. The safety of veralipride De Leo V., Morgante G., Musacchio M.C., Faldini E., Delia A., Petraglia F. Expert Opinion on Drug Safety, 5(5):695-701, 2006 457. Prenatal diagnosis and multidisciplinary approach to the congenital gingival granular cell tumor. Messina M, Severi FM, Buonocore G, Molinaro F, Amato G, Petraglia F. Journal of Pediatric Surgery; 41 (10): E35-8, 2006 458. Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness Luisi S., Estrela Borges L., Lazzeri L., Dell’Anna A., Severi F.M., Petraglia F. Fertility and Sterility, 86(5): 1483-7, 2006 459. Human endometrium expresses urocortin II and III messenger RNA and peptides Florio P., Torres P., Torricelli M., Toti P., Vale W., Petraglia F. Fertility and Sterility, 86(6):1766-70, 2006 460. Activin A in Brain Injury Florio P., Gazzolo D., Luisi S., Petraglia F. Advances in Clinical Chemistry, 2007; 43:117-30


66

461. Interleukin 1β and Progesterone Stimulate Activin A Expression and Secretion From Cultured Human Endometrial Stromal Cells. Florio P, Rossi M, Viganò P, Luisi S, Torricelli M, Torres P, Di Blasio A.M, Petraglia F. Reproductive Sciences, 14 (1): 29-36, 2007 462. Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders? Florio P, Zatelli M.C, Reis F.M, Degli Uberti E.C, Petraglia F. Frontiers in Bioscience 12 (1): 551-560, 2007 463. Increased plasma concentrations of antiprothrombin antibodies in women with recurrent spontaneous abortion. Sabatini L, Torricelli M, Scaccia V, Fineschi D, Pescaglini M, Gasparri L, Florio P, Petraglia F. Clinical Chemistry, 53 (2): 228-232, 2007 464. Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. Torricelli M, De Falco G, Florio P, Rossi M, Leucci E, Vigano P, Leoncini L, Petraglia F. Human Reproduction, 22 (1): 92-96, 2007. 465. High basal serum allopregnanolone levels in overweight girls Predieri B, Luisi S, Casarosa E, De Simone M, Balli F, Bernasconi S, Rossi M, Petraglia F, Iughetti L. International Journal of Obesity, 31 (3): 543-549, 2007 466. Early oxidative stress in amniotic fluid of pregnancies with Down sindrome. Perrone S, Longini M, Bellieni C.V, Centini G, Kenanidis A, De Marco L, Petraglia F, Buonocore G. Clinical Biochemistry, 40 (3-4): 177-180, 2007 467. High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy. Florio P, Luisi S, Moataza B, Torricelli M, Iman I, Hala M, Hanna A, Petraglia F, Gazzolo D. Clinical Chemistry 53 (3): 520-522, 2007 468. Single serum activin A testing to predict ectopic pregnancy. Florio P, Severi FM, Bocchi C, Luisi S, Mazzini M, Danero S, Torricelli M, Petraglia F. Journal of Clinical Endocrinology and Metabolism, 92 (5):1748-1753, 2007 469. Perioperative activin A concentration as a predictive marker of neurologic abnormalities in children after open heart surgery. Florio P, Abella RF, De La Torre T, Giamberti A, Luisi S, Butera G, Cazzaniga A, Frigiola A, Petraglia F, Gazzolo D. Clinical Chemistry, 53 (5): 982-985, 2007 470. Melanocytic skin lesion and pregnancy: digital dermoscopy analysis. Rubegni P, Sbano P, Burroni M, Cevenini G, BocchiC, Severi FM, Risulo M, Petraglia F, Dell’Eva G, Figiani M, Andreassi L.


67

Skin Research and Technology, 13: 143-147, 2007 471. New protocol of clomiphene citrate treatment in womaen with hypothalamic amenorrea Borges LE, Morgante G, Musacchio MC, Petraglia F, De Leo V. Ginecological Endocrinology, 23 (6): 343-346, 2007 472. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome. De Leo V, Morgante G, Piomboni P, Musacchio MC, Petraglia F, Cianci A. Fertility and Sterility, 88 (1): 113-117, 2007 473. Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. Torres PB, Florio P, Ferreira MC, Torricelli M, Reis FM, Petraglia F. Fertility and Sterility, 88 (1): 200-205, 2007 474. Total inhibin is a potential serum marker for epithelial ovarian cancer. Tsigkou A, Marrelli D, Reis FM, Luisi S, Silva-Filho AL, Roviello F, Triginelli SA, Petraglia F. Journal of Clinical Endocrinology and Metabolism, 92 (7): 2526-2531, 2007 475. The detection of anti-B2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester. Mezzesimi A, Florio P, Reis FM,D’Aniello G, Sabatini L, Razzi S, Fineschi D, Petraglia F. European Journal of Obstetrics & Gynecology and Reproductive Biology, 133: 164-168, 2007 476. Placental Neurokinin B mRNA Expression Increases at Preterm Labor Torricelli M, Giovannelli A, Leucci E, Florio P, De Falco G, Torres P.B, Reis F.M, Leoncini L, Petraglia F. Placenta, 28: 1020-1023, 2007 477. Labor (term and preterm) is associated with changes in the placental mRNA expression of corticotrophin-releasing factor. Torricelli M, Giovannelli A, Leucci E, De Falco G, Reis FM, Imperatore A, Petraglia F. Reproductive Sciences, 14 (3): 241-245, 2007 478. Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding. Reis FM, Nascimento LL, Tsigkou A, Ferreira MC, Luisi S, Petraglia F. Reproductive Sciences, 14 (4): 383-389, 2007 479. Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati, Rome, May 8-9, 2007. Gennazzani AR, Gambacciani M, Simoncini T, Anniverno R, Becorpi AM, Biglia n, Brandi ML, Guaschino S, Lello S, Massobrio M, Melis GB, Mencacci C, Modena MG, Nappi C, Nappi RE, Pecorelli S, Petraglia F, Rosano GM, Serra GB, Sismondi P, Taddei S, Tonelli F. Gynecological Endocrinology, 23 (8): 436.444, 2007


68

480. Plasma urocortin levels in the diagnosis of ovarian endometriosis Florio P, Reis FM, TorresPB, Calonaci F, Bocchi C, Linton EA, Petraglia F. Obstetrics & Gynecology, 110 (3): 594-600, 2007 481. Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration. Florio P, Lowry PJ, Benedetto C, Galleri L, Torricelli M, Giovannelli A, Battista R, Reis FM, Petraglia F. European Journal of Endocrinology, 157 (3): 279-284, 2007 482. OC282: Amniotic fluid isoprostane levels in fetuses with cystic hygroma Kenanidis A, Centini G, Rosignoli L, Scarinci R, Longini M, Perrone S, Petraglia F, Buonocore G. Ultrasound in Obstetrics and Gynecology, 30 (4): 454, 2007 483. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Razzi S, Luisi S, Calonaci F, Altomare A, Bocchi C, Petraglia F. Fertility and Sterility, 88 (4): 789-794, 2007 484. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol. Carretti N, Florio P, Reis FM, Comai S, Petraglia F, Costa CV. Climacteric, 10 (5): 393-399, 2007 485. Local drug release system in endometriosis Petraglia F, Luisi S. Gynecological Endocrinology, 23 (11): 662-664, 2007 486. Changes in the maternal serum concentration of proearly placenta insulin-like growth factor peptides in normal vs abnormal pregnancy. Bruni L, Luisi S, Ferretti C, Janneau J.L, Quadrifoglio M.C, Richon S, Dangles-Marie V, Bellet D, Petraglia F. American Journal of Obstetrics & Gynecology, 197(6): 606.e1-606.e4, 2007 487. Role of proteoglycans in the organization of periurethral connective tissue in women with stress urynary incontinence. Trabucco E, Soderberg M, Cobellis L, Torella M, Bystrom B, Ekman-Ordeberg G, Petraglia F. Maturitas, 58(4):395-405, 2007 488. Prediction of preterm delivery based on maternal plasma urocortin. Florio P, Linton E.A, Torricelli M, Faldini E, Reis F.M, Imperatore A, Calonaci G, Picciolini E, Petraglia F. Journal of Clinical Endocrinology and Metabolism, 92(12): 4734-4737, 2007 489. Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis.


69

Razzi S, Luisi S, Ferretti C, Calonaci F, Gabbanini M, Mazzini M, Petraglia F. European Journal of Obstetric Gynecology and Reproductive Biology, 135 (2):188-190, 2007 490. Adrenomedullin blood concentrations in Infants Subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Florio P, Abella R, Marinoni E, Di Iorio R, Letizia C, Meli M, de la Torre T, Petraglia F, Cazzaniga A, Giamberti A, Frigiola A, Gazzolo D. Clinical Chemistry, 54(1): 202-206, 2008 491. Hormone-dependent gynaecological disorders: a pathophysiological perspective for appropriate treatment. Petraglia F, Musacchio C, Luisi S, De Leo V. Best Practice & Research Clinical Obstetrics and Gynaecology, 22 (2): 235-249, 2007 492 Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. Florio P, Bruni L, De Falco C, Filardi G, Torricelli M, Reis FM, Galleri L, Bocchi C, De Leo V, Petraglia F. Clinical Chemistry, 54 (2): 350-355, 2008 493. An informative probability model enhancing real time echobiometry to improve fetal weight estimation accuracy Cevenini G, Severi FM, Bocchi C, Petraglia F, Barbini P. Medical & Biological Engineering and Computing, 46(2): 109-120, 2008 494. Inhibins as diagnostic markers in human reproduction Tsigkou A, Luisi S, Reis FM, Petraglia F. Advances in Clinical Chemistry 45: 1-29, 2008 495. High serum inhibin concentration discriminates autoimmune oophoritis from ather forms of primary ovarian insufficiency. Tsigkou A, Marzotti S, Borges L, Brozzetti A, Reis F, Candeloro P, Bacosi ML, Petraglia F. Journal of Clinical Endocrinology and Metabolism, 93(4): 1263-9, 2008 496. Activin A increases invasiveness of endometrial cells in an in-vitro model of human peritoneum Ferreira M, Witz C, Hammes L, Petraglia F, Schenken R, Reis F. Molecular Human Reproduction, 14 (5): 301-307, 2008 497. The Increase of blood flow in the fetal middle cerebral artery correlates with the onset of labor at term. Severi FM, Boni C, Bruni L, Bocchi C, Aguiar R.A, Reis, F.M, Petraglia F. Reproductive Sciences 15 (6): 584-590,2008


70

498. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing ((R)) Bruni V, Pontello V, Luisi S, Petraglia F. European Journal of Obstetrics, Gynecology and Reproductive Biology,139 (1):65-71, 2008 499. Consumerism in prenatal diagnosis? A local Italian Study Bellieni CV, Maffei M, Brogna A, Plantulli A, Cervo E, Reda M, Signorini L, Buonocore G, Petraglia F. Fetal Diagnosis Therapy, 24 (1): 29-34, 2008 500. Amniotic fluid and umbilical cord plasma corticotropin-releasing factor (CRF), CRF-binding protein, adrenocorticotropin and cortisol concentrations in intraamniotic infection and inflammation at term. Florio P, Romero R, Chaiworapongsa T, Kusanovic JP, Torricelli M, Lowry PJ, Petraglia F. Journal of Clinical Endocrinology and Metabolism, 93(9): 3604-9, 2008 501. Morphogenesis of human endothelial cells is inhibited by DAB2 via Src. Orlandini M, Nucciotti S, GalvagniF, Bardelli M, Rocchigiani M, Petraglia F, Oliviero S. FEBS Lett.2008 582(17):2542-8 502. Thickness of fetal membranes: a possible ultrasound marker for preterm delivery Severi FM, Bocchi C, Voltolini C, Borges LE, Florio P, Petraglia F. Ultrasound in Obstetric and Gynecology, 32 (2): 205-9, 2008 503. High serum concentration of total inhibin in polycistic ovary syndrome. Tsigkou A, Luisi S, De Leo V, Patton L, Gambineri A, Reis FM, Pasquali R, Petraglia F. Fertility and Sterility, 90(5): 1859-63, 2008 504. Changes of placental Kiss-1 mRNA expression and maternal/cord kisspeptin levels at preterm delivery. Torricelli M, Galleri L, Voltolini C, Biliotti G, Florio P, De Bonis M, Petraglia F. Reproductive Sciences, 15 (8): 779-784, 2008 505. Activin betaA subunit, follistatin and follistatin-like 3 are espresse in the endometrium of ovariectomized rats and regulated by estrogen replacement. Ferreira MC, Cavallo IK, Florio P, Petraglia F, Reis FM. Journal of Molecular Histology, 39 (5): 535-41, 2008 506.Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL 10) in women with endometriosis. Galleri L, Luisi S, Rotondi M, Cobellis L, Serio M, Petraglia F. Fertility Sterility, 91(2):331-4, 2008


71

507.Follicle-stimulating hormone receptor and DAZL gene polymorphisms do not affect the age of menopause. Zerbetto I, Gromoll J, Reis F.M, Nieschleg E, Simoni M, Petraglia F. Fertility and Sterility,90(6): 2264-8,2008 508. Efficacy of vaginal Danazol treatment in women with menorrhagia during fertile age Luisi s, Razzi S, Lazzeri L, Bocchi C, Severi FM, Petraglia F. Fertility and Sterility, ;92(4):1351-4, 2008 509.Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. Gazzolo D, Frigiola A, Bashir M, Iskander I, Mufeed H, Aboulgar H, Venturini P, Marras M, Serra G, Frulio R, Michetti F, Abella R, Florio P, Petraglia F. PLOS ONE, 4(2) : e4298 ,2009 510. Evaluation of endometrial activin A secretion for prediction of pregnancy after intrauterine insemination. Florio P, Bruni L, Galleri L, Reis FM, Borges LE, Bocchi C, Litta P, De Leo V, Petraglia F. Fertility and sterility, ;93(7):2316-20., 2009 511. Inflammation and pregnancy Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F. Reproductive Sciences,16(2) : 206-15, 2009 512.Activin A, activin receptor type II, nodal, and cripto mRNA are expressed by eutopic and ectopic endometrium in women with ovarian endometriosis. Torres PB, Florio P, Galleri L, Reis FM, Borges LE, Petraglia F. Reprod Sciences,16(8):727-33,2009 513. Relaxin in endometriosis. Morelli SS, Weiss G, Luisi S, Florio P, Goldsmith LT, Petraglia F. Ann N Y Acad Sci.;1160:138-9, 2009 514. Urocortin 2 stimulates estradiol secretion from cultured human placental cells: an effect mediated by the type 2 corticotrophin-releasing hormone (CRH) receptor. Imperatore A, Li W, , Challis JR., Petraglia F. Reproductive Sciences, 16(6):551-8,2009 515. Urocortin in amniotic fluid and Down syndrome. Torricelli M, Voltolini C, Biliotti G, Giorlandino C, De Pascalis F, De Bonis M, Mesuraca A, Giovannelli A, Pecciarini L, Petraglia F. Prenat Diag ,29(8):806-7,2009


72

516. Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. Hernádi L, Marr J, Trummer D, De Leo V, Petraglia F. Contraception.,80(1):18-24,2009 517. Increased maternal/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Garnier Y, Frigiola A, Li Volti G, Florio P, Frulio R, Berger R, Alm S, von Duering MU, Coumans AB, Reis FM, Hasaart TH, Abella R, Mufeed H, Gazzolo D, Petraglia F. Reproductive Sciences,16(8):758-66, 2009 518. High serum follistatin levels in women with ovarian endometriosis. Florio P, Reis FM, Torres PB, Calonaci F, Abrao MS, Nascimento LL, Franchini M, Cianferoni L, Petraglia F. Human Reproduction ,24(10):2600-6, 2009

519. Amniotic fluid urocortin, CRF, oestriol, dehydroepiandrosterone sulfate and cortisol concentrations at mid-trimester: putative relationship with preterm delivery. Torricelli M, Voltolini C, Galleri L, Biliotti G, Giovannelli A, De Bonis M, De Pascalis F, Centini G, Petraglia F. Eur J Obstet Gynecol Reprod Biology;146(2):169-73,2009

520. Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells. Torricelli M, Voltolini C, Bloise E, Biliotti G, Giovannelli A, De Bonis M, Imperatore A, Petraglia F. Am J Reprod Immunology,62(4):224-31,2009

521. Levels of antibodies against protein C and protein S in pregnancy and in preeclampsia. Torricelli M, Sabatini L, Florio P, Scaccia V, Voltolini C, Biliotti G, De Bonis M, Petraglia F. J Matern Fetal Neonatal Medicine,;22(11):993-9,2009

522. Endometriosis in Italy: from cost estimates to new medical treatment. Luisi S, Lazzeri L, Ciani V, Petraglia F. Gynecol Endocrinology, 25(11):734-40, 2009

523. Oral contraceptives after myomectomy: a short term trial. Luisi S, Ciani V, Gabbanini M, Sollazzi S, Torricelli M, Calonaci F, Petraglia F. Int J Endocrinol,:476897,2009

524. Differential expression of follistatin and FLRG in human breast proliferative disorders. Bloise E, Couto HL, Massai L, Ciarmela P, Mencarelli M, Borges LE, Muscettola M, Grasso G, Amaral VF,Cassali GD, Reis FM, Petraglia F BMC Cancer,9;9:320,2009


73

525. Prevention and management of preterm labour. Visser GH., Petraglia F. J Matern Fetal Neonatal Med.;22 Suppl 2:24-30, 2009 526. Polycystic ovary syndrome and metabolic comorbidities: therapeutic options. De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F. Drugs Today (Barc).;45(10):763-75, 2009 527.Polymorphisms of FAS and FAS ligand genes in preeclamptic women. Ciarmela P, Boschi S, Bloise E, Marozio L, Benedetto C, Castellucci M, Petraglia F. Eur J Obstet Gynecol Reprod Biol.;148(2):144-6,2010 528.Biochemical markers of perinatal brain damage. Florio P, Abella R, Marinoni E, Di Iorio R, Li Volti G, Galvano F, Pongiglione G, Frigiola A, Pinzauti S, Gazzolo D, Petraglia F. Front Biosci (Schol Ed). 1;2:47-72, 2010 529. Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes. Carretti N, Florio P, Reis FM, Comai S, Bertazzo A, Petraglia F. Climacteric.,13(2):141-6, 2010 530. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. Dubicke A, Fransson E, Centini G, Andersson E, Byström B, Malmström A, Sverremark-Ekström E, Ekman-Ordeberg G, Petraglia F. J Reprod Immunol.,84(2):176-85,2010 531. Activins and related proteins in the establishment of pregnancy. Florio P, Gabbanini M, Borges LE, Bonaccorsi L, Pinzauti S, Reis FM, Boy Torres P, Rago G, Litta P, Petraglia F. Reprod Sci;17(4):320-30,2010 532.Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Galvagni F, Pennacchini S, Salameh A, Rocchigiani M, Neri F, Orlandini M, Petraglia F.,Gotta S, Sardone GL, Matteucci G, Terstappen GC, Oliviero S. Circ Res.;106(12):1839-48, 2010 533. Review: Human reproduction in art: from myths to history. Petraglia F, Bettini M. Reprod Sci.;17(8):711-7,2010 534.The use of nomegestrol acetate in rapid preparation of endometrium before operative hysteroscopy in pre-menopausal women. Florio P, Imperatore A, Litta P, Franchini M, Calzolari S, Angioni S, Gabbanini M, Bruni L, Petraglia F.


74

Steroids.;75(12):912-7,2010 535.Placental hormones and identification of pregnancy at risk. Torricelli M, Petraglia F. Gynecol Endocrinol.;26(10):705-,2010

536. S100B protein increases in human blood and urine during stressful activity. Gazzolo D, Florio P, Zullino E, Giovannini L, Scopesi F, Bellini C, Peri V, Mezzano P, Petraglia F, Michetti F. Clin Chem Lab Med.;48(9):1363-5,2010 537.Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3. Imperatore A, Rolfo A, Petraglia F, Challis JR, Caniggia I. Reprod Sci.;17(9):833-43,2010

538. Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primary trophoblast cells. Bloise E, Torricelli M, Novembri R, Borges LE, Carrarelli P, Reis FM, Petraglia F. Placenta.;31(10):867-72,2010 539.Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. De Leo V, Di Sabatino A, Musacchio MC, Morgante G, Scolaro V, Cianci A, Petraglia F. Contraception.;82(3):276-80,2010 540.A randomized controlled study comparing carbon dioxide versus normal saline as distension media in diagnostic office hysteroscopy: is the distension with carbon dioxide a problem? Raimondo G, Raimondo D, D'Aniello G, Russo C, Ronga A, Gabbanini M, Filippeschi M, Florio P, Petraglia F. Fertil Steril.;94(6):2319-22,2010 541. Patients with functional hypothalamic amenorrhea are characterized by low serum inhibin B concentrations. Podfigurna-Stopa A, Luisi S, Lazzeri L, Ciani V, Meczekalski B, Petraglia F. Pol Merkur Lekarski. ; 28(167):350-3,2010 542. Neuroendocrine mechanisms in pregnancy and parturition. Petraglia F, Imperatore A, Challis JR. Endocr Rev.;31(6):783-816,2010 543. Endometrial expression of relaxin and relaxin receptor in endometriosis. Morelli SS, Petraglia F, Weiss G, Luisi S, Florio P, Wojtczuk A, Goldsmith LT. Fertil Steril.;94(7):2885-7,2010


75

544. Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation. Bloise E, Cassali GD, Ferreira MC, Ciarmela P, Petraglia F, Reis FM. J Dairy Sci.;93(10):4592-601,2010 545. A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. Litta P, Fantinato S, Calonaci F, Cosmi E, Filippeschi M, Zerbetto I, Petraglia F, Florio P. Fertil Steril. 2010 Oct;94(5):1882-6,2010 546.Inflammatory and infectious risk factors are associated with the response to tocolysis in patients with preterm labor. Torricelli M, Voltolini C, Conti N, De Bonis M, Biliotti G, Picciolini E, Petraglia F. J Matern Fetal Neonatal Med.;24(1):43-6,2011 547.Biochemical and biophysical predictors of the response to the induction of labor in nulliparous postterm pregnancy. Torricelli M, Novembri R, Voltolini C, Conti N, Biliotti G, Piccolini E, Cevenini G, Smith R, Petraglia F. Am J Obstet Gynecol ;204(1):39.e1-6,2011 548. Corticotrophin-releasing factor and urocortin inhibit system A activity in term human placental villous explants. Giovannelli A, Greenwood SL, Desforges M, Sibley CP, Petraglia F. Placenta.;32(1):99-101,2011 549.Changes in Placental CRH, Urocortins, and CRH-Receptor mRNA Expression Associated with Preterm Delivery and Chorioamnionitis. Torricelli M, Novembri R, Bloise E, De Bonis M, Challis JR, Petraglia F. J Clin Endocrinol Metab.;96(2):534-40,2011 550. Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty. Predieri B, Luisi S, Casarosa E, Farinelli E, Antoniazzi F, Wasniewska M, Bernasconi S, Petraglia F, Iughetti L; Italian Society of Pediatric Endocrinology and Diabetology - Study Group of Puberty. J Endocrinol Invest.;34(1):38-44,2011 551. Attenuated tubal and endometrial urocortin 1 and corticotropin-releasing hormone receptor expression in ectopic pregnancy. Borges LE, Horne AW, McDonald SE, Shaw JL, Lourenco PC, Petraglia F, Critchley HO. Reprod Sci.;18(3):261-8,2011

552. Circulating Levels of Allopregnanolone, a Neuroactive Steroid, and Leptin during Treatment with Valproic Acid in Children with Epilepsy. Grosso S, Luisi S, Mostardini R, Matera M, Barlocco EG, Casarosa E, Balestri P, Petraglia F. Neuroendocrinology.;93(3):159-64,2011


76

553. Activin-a and myostatin response and steroid regulation in human myometrium: disruption of their signalling in uterine fibroid. Ciarmela P, Bloise E, Gray PC, Carrarelli P, Islam MS, De Pascalis F, Severi FM, Vale W, Castellucci M, Petraglia F. J Clin Endocrinol Metab.;96(3):755-65,2011 554. A retrospective case-control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele. Florio P, Gubbini G, Marra E, Dores D, Nascetti D, Bruni L, Battista R, Moncini I, Filippeschi M, Petraglia F. Gynecol Endocrinol,;27(6):434-8.2011

555. Serum activin A levels are lower in tubal than intrauterine spontaneously conceived pregnancies. Florio P, Reis FM, Battista R, Luisi S, Moncini I, Bocchi C, Severi FM, Petraglia F. Gynecol Endocrinol, 27(6):391-5,2011

556. Impaired CRH and Urocortin Expression and Function in Eutopic Endometrium of Women with Endometriosis. Novembri R, Borges LE, Carrarelli P, Rocha AL, De Pascalis F, Florio P, Petraglia F. J Clin Endocrinol Metab, 96(4):1145-50,2011 557.Surgical hysteroscopic treatment of cesarean-induced isthmocele in restoring fertility: prospective study. Gubbini G, Centini G, Nascetti D, Marra E, Moncini I, Bruni L, Petraglia F, Florio P. J Minim Invasive Gynecol.;18(2):234-7,2011

558. Urocortin2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. Novembri R, Carrarelli P, Toti P, Rocha AL, Borges LE, Reis FM, Piomboni P, Florio P, Petraglia F. Mol Hum Reprod, 17(9):587-93,2011 559.Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma. Rocha AL, Carrarelli P, Novembri R, Sabbioni L, Luisi S, Reis FM, Petraglia F. Fertil Steril.;95(7):2241-6,2011 560. Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 µg compared with a 21/7 regimen of desogestrel 150 µg/ethinylestradiol 20 µg: a pooled analysis. Anttila L, Neunteufel W, Petraglia F, Marr J, Kunz M. Clin Drug Investig.;31(8):519-25,2011 561. High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus.


77

Torricelli M, Bellisai F, Novembri R, Galeazzi LR, Iuliano A, Voltolini C, Spreafico A, Galeazzi M, Petraglia F. Am J Reprod Immunol.;66(2):84-9,2011 562. Sex Steroid Hormones and Reproductive Disorders: Impact on Women's Health. Fauser BC, Laven JS, Tarlatzis BC, Moley KH, Critchley HO, Taylor RN, Berga SL, Mermelstein PG, Devroey P, Gianaroli L, D'Hooghe T, Vercellini P, Hummelshoj L, Rubin S, Goverde AJ, Leo VD, Petraglia F. Reprod Sci.;18(8):702-12,2011 563.Possible role of RKIP in cytotrophoblast migration: immunohistochemical and in vitro studies. Ciarmela P, Marzioni D, Islam MS, Gray PC, Terracciano L, Lorenzi T, Todros T, Petraglia F, Castellucci M. J Cell Physiol,doi: 10.1002/jcp.22907,2011 564. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W, Castellucci M. Hum Reprod Update,;17(6):772-90, 2011 565. Identification of preterm labor: the role of the firbronectine and ultrasound cervicometry and their association.] Di Renzo GC, Giardina I, Coata G, Di Tommaso M, Facchinetti F, Petraglia F, Tranquilli AL, Rizzo N. Minerva Ginecol,;63(6):477-483,2011 566.Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants. Novembri R, Torricelli M, Bloise E, Conti N, Galeazzi LR, Severi FM, Petraglia F. Placenta,;32(12):969-74,2011 567.Maternal risk factors for preterm birth: a country-based population analysis. Di Renzo GC, Giardina I, Rosati A, Clerici G, Torricelli M, Petraglia F; the Italian Preterm Network Study Group. Eur J Obstet Gynecol Reprod Biol,;159(2):342-346,.2011 568. Clinical outcomes associated with surgical treatment of endometrioma coupled with resection of the posterior broad ligament. Mereu L, Florio P, Carri G, Pontis A, Petraglia F, Mencaglia L. Int J Gynaecol Obstet.;116(1):57-60,2012 569. Low-dose spinal anesthesia with hyperbaric bupivacaine with intrathecal fentanyl for operative hysteroscopy: a case series study. Florio P, Puzzutiello R, Filippeschi M, D'Onofrio P, Mereu L, Morelli R, Marianello D, Litta P, Mencaglia L, Petraglia F. J Minim Invasive Gynecol.;19(1):107-12,2012


78

570.Use of venlafaxine in psychiatric disorders and climacteric syndrome: is a therapeutic bridge? Luisi S, Castrogiovanni A, Ciani V, Pacchierotti C, Capua AD, Pasquini R, Lazzeri L, Petraglia F. Gynecol Endocrinol.;28(1):68-71,2012 571.Consensus on women's health aspects of polycystic ovary syndrome (PCOS).The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Hum Reprod.;27(1):14-24,2012 572. A novel antiinflammatory role for the short-chain Fatty acids in human labor. Voltolini C, Battersby S, Etherington SL, Petraglia F, Norman JE, Jabbour HN. Endocrinology.;153(1):395-403,2012

573.Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K. Fertil Steril.;97(1):28-38.e25,2012 574. Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa. Luisi S, Ciani V, Podfigurna-Stopa A, Lazzeri L, De Pascalis F, Meczekalski B, Petraglia F. Gynecol Endocrinol,28(1):34-8,2012 575.Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, Lazzeri L, Strowitzki T. Arch Gynecol Obstet.;285(1):167-73,2012 576. Maternal serum protein S forms in pregnancies complicated by intrauterine growth restriction. De Bonis M, Sabatini L, Galeazzi LR, Torricelli M, Calzoni P, Fineschi D, Novembri R, Severi FM, Petraglia F. Eur J Obstet Gynecol Reprod Biol.;160(2):142-6,2012 577.Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis. Reis FM, Luisi S, Abrão MS, Rocha AL, Viganò P, Rezende CP, Florio P, Petraglia F. Hum Reprod.;27(5):1445-50,2012


79

578. The International Society of Gynecological Endocrinology and its president. Naftolin F, Petraglia F, Simoncini T. Gynecol Endocrinol.;28 Suppl 1:1,2012 579. The identification of high risk pregnancy: a new challenge in obstetrics. Torricelli M, Voltolini C, De Bonis M, Vellucci FL, Conti N, Severi FM, Petraglia F. J Matern Fetal Neonatal Med.;25 Suppl 1:2-5,2012 580. Neuroendocrine aspects of placenta and pregnancy. De Bonis M, Torricelli M, Severi FM, Luisi S, De Leo V, Petraglia F. Gynecol Endocrinol.;28 Suppl 1:22-6,2012 581. Activin a stimulates interleukin 8 and vascular endothelial growth factor release from cultured human endometrial stromal cells: possible implications for the pathogenesis of endometriosis. Rocha AL, Carrarelli P, Novembri R, de Pascalis F, Luisi S, Reis FM, Petraglia F. Reprod Sci. ;19(8):832-8,2012

582. Ultrasound estimated fetal weight slightly below the median is associated with increased risk of spontaneous preterm birth. Severi FM, Bocchi C, Imperatore A, Boni C, Ferrata C, Florio P, Reis FM, Petraglia F. Prenat Diagn.;32(6):588-91,2012 583. Impaired placental nutrient transport in mice generated by in vitro fertilization. Bloise E, Lin W, Liu X, Simbulan R, Kolahi KS, Petraglia F, Maltepe E, Donjacour A, Rinaudo P. Endocrinology.;153(7):3457-67,2012 584. New trends for the medical treatment of endometriosis. Rocha AL, Reis FM, Petraglia F. Expert Opin Investig Drugs.;21(7):905-19,2012 585. Inflammation: a link between endometriosis and preterm birth. Petraglia F, Arcuri F, de Ziegler D, Chapron C. Fertil Steril.;98(1):36-40,2012 586. RKIP and cytotrophoblast motility. Ciarmela P, Marzioni D, Islam MS, Gray PC, Terracciano L, Lorenzi T, Todros T, Petraglia F, Castellucci M. J Cell Physiol.;227(12):3895,2012 587. Correlation with placental kisspeptin in postterm pregnancy and apoptosis. Torricelli M, Novembri R, Conti N, De Falco G, De Bonis M, Petraglia F. Reprod Sci.;19(10):1133-7,2012


80

588. Clinical use of placental hormones in pregnancy management. De Bonis M, Vellucci FL, Di Tommaso M, Voltolini C, Torricelli M, Petraglia F. J Endocrinol Invest.;35(8):776-81,2012 589.Present and future of recombinant gonadotropins in reproductive medicine. De Leo V, Musacchio MC, Di Sabatino A, Tosti C, Morgante G, Petraglia F. Curr Pharm Biotechnol.;13(3):379-91; 2012 Review 590. Activin a and its regulatory molecules in placenta and fetal membranes of women with preterm premature rupture of the membranes associated with acute chorioamnionitis. Torricelli M, Voltolini C, Novembri R, Bocchi C, Di Tommaso M, Severi FM, Petraglia F. Am J Reprod Immunol.;68(5):392-9,2012 591. Carbetocin versus oxytocin after caesarean section: similar efficacy but reduced pain perception in women with high risk of postpartum haemorrhage. De Bonis M, Torricelli M, Leoni L, Berti P, Ciani V, Puzzutiello R, Severi FM, Petraglia F. J Matern Fetal Neonatal Med ;25(6):732-5,2012 592. Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing. Torricelli M, Voltolini C, Conti N, Vellucci FL, Orlandini C, Bocchi C, Severi FM, Toti P, Buonocore G, Petraglia F. J Matern Fetal Neonatal Med.;26(2):188-92,2013 593. Fetal sex and preterm birth. Challis J, Newnham J, Petraglia F, Yeganegi M, Bocking A. Placenta.;34(2):95-9,2013 594. Uterine fibroids affect pregnancy outcome in women over 30 years old: role of other risk factors. Conti N, Tosti C, Pinzauti S, Tomaiuolo T, Cevenini G, Severi FM, Di Tommaso M, Petraglia F. J Matern Fetal Neonatal Med.;26(6):584-7,2013 595. Onward and upward. Collins J, Petraglia F. Hum Reprod Update.;19(2):85-6, 2013 596. Uterine leiomyoma: available medical treatments and new possible therapeutic options. Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, Castellucci M, Ciarmela P. J Clin Endocrinol Metab.;98(3):921-34,2013 597. Epidemiology of early pre-term delivery: Relationship with clinical and histopathological infective parameters.


81

Torricelli M, Conti N, Galeazzi LR, Di Renzo GC, Petraglia F;Italian Pre-Term Network Study Group 3. J Obstet Gynaecol.;33(2):140-3.,2013 598. Defining future directions for endometriosis research: workshop report from the 2011 world congress of endometriosis in montpellier, france. Rogers PA, D'Hooghe TM, Fazleabas A, Giudice LC, Montgomery GW, Petraglia F, Taylor RN. Reprod Sci.;20(5):483-99,2013 599. Intrauterine volvulus with malrotation: prenatal diagnosis. Varetti C, Meucci D, Severi F, Di Maggio G, Bocchi C, Petraglia F, Messina M. Minerva Pediatr. ;65(2):219-23,2013 600. Chronic Pelvic Pain and Quality of Life in Women with and without Endometriosis Centini G., Lazzeri. L., Dores D., Pianigiani L., Iannone P., Luisi S, Petraglia F.,Zupi E. Journal of Endometriosis and Pelvic Pain Disorders, 5(1):27-33,2013 601. Fetal gender effects on induction of labor in postdate pregnancies. Torricelli M, Voltolini C, Vellucci FL, Conti N, Bocchi C, Severi FM, Challis JR, Smith R, Petraglia F. Reprod Sci.;20(6):670-4, 2013 602. Weight gain regardless of pre-pregnancy BMI and influence of fetal gender in response to labor induction in postdate pregnancy. Torricelli M, Voltolini C, Conti N, Bocchi C, Severi FM, Petraglia F. J Matern Fetal Neonatal Med.;26(10):1016-9,2013 603. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Reis FM, Petraglia F, Taylor RN. Hum Reprod Update.;19(4):406-18,2013

604. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Islam MS, Protic O, Stortoni P, Grechi G, Lamanna P, Petraglia F, Castellucci M, Ciarmela P. Fertil Steril.;100(1):178-93,2013

605. Understanding spontaneous preterm birth: from underlying mechanisms to predictive and preventive interventions. Voltolini C, Torricelli M, Conti N, Vellucci FL, Severi FM, Petraglia F. Reprod Sci.;20(11):1274-92,2013

606. Postdate pregnancy: Changes of placental/membranes 11β-hydroxysteroid dehydrogenase mRNA and activity. Novembri R, Voltolini C, Torricelli M, Severi FM, Marcolongo P, Benedetti A, Challis JR, Petraglia F. Placenta.;(11):1102-4,2013


82

607. The changing prevalence of infertility. Petraglia F, Serour GI, Chapron C. Int J Gynaecol Obstet.;123 Suppl 2:S4-8,2013

608. Management of infertility today. Petraglia F, Chapron C, Pegoraro R. Int J Gynaecol Obstet.;123 Suppl 2:S1,2013

609. Hormone replacement therapy in menopause and in premature ovarian insufficiency. Luisi S, Orlandini C, Biliotti G, Scolaro V, De Felice G, Regini C, Petraglia F. Minerva Ginecol.;65(6):607-20,2013 610. Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function. Islam MS, Catherino WH, Protic O, Janjusevic M, Gray PC, Giannubilo SR, Ciavattini A, Lamanna P, Tranquilli AL, Petraglia F, Castellucci M, Ciarmela P. J Clin Endocrinol Metab.;99(5):E775-85;2014 611. Increased expression of antimüllerian hormone and its receptor in endometriosis. Carrarelli P, Rocha AL, Belmonte G, Zupi E, Abrão MS, Arcuri F, Piomboni P, Petraglia F. Fertil Steril.;101(5):1353-8;2014 612. Ultrasound mapping system for the surgical management of deep infiltrating endometriosis. Exacoustos C, Malzoni M, Di Giovanni A, Lazzeri L, Tosti C, Petraglia F, Zupi E. Fertil Steril.;102(1):143-150.e2;2014 613. Preoperative and Postoperative Clinical and Transvaginal Ultrasound Findings of Adenomyosis in Patients With Deep Infiltrating Endometriosis. Lazzeri L, Di Giovanni A, Exacoustos C, Tosti C, Pinzauti S, Malzoni M, Petraglia F, Zupi E. Reprod Sci.;21(8):1027-1033;2014 614. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea. Petraglia F, Parke S, Serrani M, Mellinger U, Römer T. Int J Gynaecol Obstet.;125(3):270-4;2014 615. Ulipristal acetate modulates the expression and functions of activin a in leiomyoma cells. Ciarmela P, Carrarelli P, Islam MS, Janjusevic M, Zupi E, Tosti C, Castellucci M, Petraglia F. Reprod Sci.;21(9):1120-5;2014

616. Histologic chorioamnionitis: different histologic features at different gestational ages.


83

Torricelli M, Voltolini C, Toti P, Vellucci FL, Conti N, Cannoni A, Moncini I, Occhini R, Severi FM, Petraglia F. J Matern Fetal Neonatal Med.;27(9):910-3;2014

617.FOXL2 in human endometrium: hyperexpressed in endometriosis. Governini L, Carrarelli P, Rocha AL, Leo VD, Luddi A, Arcuri F, Piomboni P, Chapron C, Bilezikjian LM, Petraglia F. Reprod Sci.;21(10):1249-55;2014

618. IL-1β and TGF-β weaken the placental barrier through destruction of tight junctions: an in vivo and in vitro study. Tossetta G, Paolinelli F, Avellini C, Salvolini E, Ciarmela P, Lorenzi T, Emanuelli M, Toti P, Giuliante R, Gesuita R, Crescimanno C, Voltolini C, Di Primio R, Petraglia F, Castellucci M, Marzioni D. Placenta. ;35(7):509-16;2014 619. Expression of Nodal, Cripto, SMAD3, Phosphorylated SMAD3, and SMAD4 in the Proliferative Endometrium of Women With Endometriosis. Dela Cruz C, Puerto HL, Rocha AL, Cavallo IK, Clarizia AD, Petraglia F, Reis FM. Reprod Sci. 2014 620.Neuroendocrinology of pregnancy and parturition. Voltolini C, Petraglia F. Handb Clin Neurol. ;124:17-36;2014 621.Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome. Conti N, Cevenini G, Vannuccini S, Orlandini C, Valensise H, Gervasi MT, Ghezzi F, Di Tommaso M, Severi FM, Petraglia F. J Matern Fetal Neonatal Med. ;9:1-4;2014 622. Parenterally Administered Moderate Sedation and Paracervical Block Versus General Anesthesia for Hysteroscopic Polypectomy: A Pilot Study Comparing Postoperative Outcomes. Centini G, Calonaci A, Lazzeri L, Tosti C, Palomba C, Puzzutiello R, Luisi S, Petraglia F, Zupi E. J Minim Invasive Gynecol.;22(2):193-8.;2015 623. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition. Voltolini C, Battersby S, Novembri R, Torricelli M, Severi FM, Petraglia F, Norman JE. Endocrinology.;156(2):670-679;2015 624. Surgical treatment affects perceived stress differently in women with endometriosis: correlation with severity of pain. Lazzeri L, Vannuccini S, Orlandini C, Luisi S, Zupi E, Nappi RE, Petraglia F. Fertil Steril.;103(2):433-8;2015


84

625. Ogilvie's syndrome in an obstetric patients: a case report. Orlandini C, Regini C, Vellucci FL, Voltolini C, Luisi S, Mariani F, De Franco L, Petraglia F. Minerva Ginecol;67(5):486-7;2015 626.Anterior placental location influences onset and progress of labor and postpartum outcome. Torricelli M, Vannuccini S, Moncini I, Cannoni A, Voltolini C, Conti N, Di Tommaso M, Severi FM, Petraglia F. Placenta.;36(4):463-6;2015 627. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Int J Gynaecol Obstet.;128(3):196-200;2015

628. Term histologic chorioamnionitis: a heterogeneous condition. Conti N, Torricelli M, Voltolini C, Vannuccini S, Clifton VL, Bloise E, Petraglia F. Eur J Obstet Gynecol Reprod Biol.;188:34-38;2015

629.Adenomyosis by transvaginal ultrasonographic features in nulligravid women without endometriosis aged 18-30 years: correlation with symptoms. Pinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi S, Zupi E, Exacoustos C, Petraglia F. Ultrasound Obstet Gynecol. 2015 Feb 26 (Epub ahead of print)

630. Autophagy is upregulated in ovarian endometriosis: a possible interplay with p53 and heme oxygenase-1. Allavena G, Carrarelli P, Del Bello B, Luisi S, Petraglia F, Maellaro E. Fertil Steril.;(15)00129-6; 2015

631. Neuroendocrine and stress-related aspects of endometriosis. Luisi S, Pizzo A, Pinzauti S, Zupi E, Centini G, Lazzeri L, Di Carlo C, Petraglia F. Neuro Endocrinol Lett.;19;36(1);2015

632. Deep endometriosis infiltrating the recto-sigmoid: critical factors to consider before management. Abrão MS, Petraglia F, Falcone T, Keckstein J, Osuga Y, Chapron C. Hum Reprod Update.;21(3):329-339;2015 633.Endometriosis and Perceived Stress: Impact of Surgical and Medical Treatment. Lazzeri L, Orlandini C, Vannuccini S, Pinzauti S, Tosti C, Zupi E, Nappi RE, Petraglia F. Gynecol Obstet Invest ;79(4):229-33;2015


85

634. The influence of doctor-patient and midwife-patient relationship in quality care perception of italian pregnant women: an exploratory study. Andrissi L, Petraglia F, Giuliani A, Severi FM, Angioni S, Valensise H, Vannuccini S, Comoretto N, Tambone V. PLoS One; 10(4):1-12;2015 635. Placenta expresses anti-Müllerian hormone and its receptor: sex-related difference in fetal membranes Novembri R, Funghi L, Voltolini C, Belmonte G, Vannuccini S, Torricelli M, Petraglia F Placenta; 36(7):731-7; 2015 636.Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for abnormal uterine bleeding: long term follow-up of a prospective randomized trial. Zupi E, Centini G, Lazzeri L, Finco A, Exacoustos C, Afors K, Zullo F, Petraglia F. J Minim Invasive Gynecol;22(5):841-5;2015 637. Increased progesterone receptor expression in uterine leiomyoma:correlation with age, number of leiomyomas, and clinical symptoms Tsigkou A, Reis F, Lee M , Jiang B, Tosti C, Centini G, Shen F-R,Chen Y-G, Petraglia F Fertil Steril;104(1):170-175;2015 638. Premature ovarian insufficiency: from pathogenesis to clinical management. Luisi S, Orlandini C, Regini C, Pizzo A, Vellucci F, Petraglia F. J Endocrinol Invest.; 38(6):597-603; 2015 639. Human pericytes isolated from adipose tissue have better differentiation abilities than their mesenchymal stem cell counterparts. Pierantozzi E, Badin M, Vezzani B, Curina C, Randazzo D, Petraglia F, Rossi D, Sorrentino V. Cell Tissue Res.; 361(3):769-78; 2015 640. The Targeted Delivery of Interleukin 4 Inhibits Development of Endometriotic Lesions in a Mouse Model. Quattrone F, Sanchez AM, Pannese M, Hemmerle T, Viganò P, Candiani M, Petraglia F, Neri D, Panina-Bordignon P. Reprod Sci; 22(9):1143-52; 2015 641.Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis. Carrarelli P, Yen CF, Arcuri F, Funghi L, Tosti C, Wang TH, Huang JS, Petraglia F. Fertil Steril.;104(3):744-752;2015 642.Pathogenetic Mechanisms of Deep Infiltrating Endometriosis. Tosti C, Pinzauti S, Santulli P, Chapron C, Petraglia F.


86

Reprod Sci. ;22(9):1053-9; 2015

643. Mood disorders and quality of life in polycystic ovary syndrome. Podfigurna-Stopa A, Luisi S, Regini C, Katulski K, Centini G, Meczekalski B, Petraglia F. Gynecol Endocrinol.;31(6):431-4; 2015 644.Genes involved in the pathogenesis of Premature Ovarian Insufficiency. Orlandini C, Regini C, Vellucci FL, Petraglia F, Luisi S. Minerva Ginecol; 67(5):421-30;2015 645.Expression levels of myostatin and matrix metalloproteinase 14 mRNAs in uterine leiomyoma are correlated with dysmenorrhea Tsigkou A, Reis F, Pasquapina C, Lee M ,Jiang B, Tosti C,Shen F-R,Chen Y-G, Petraglia F, Reprod Sci, 2015(Epub ahead of print) 646. Clarification of scope for Human Reproduction and Molecular Human Reproduction. Barratt CL, Evers JL, Petraglia F. Mol Hum Reprod.;21(9):687;2015 647.Clarification of scope for Human Reproduction and Molecular Human Reproduction. Evers JL, Barratt CL, Petraglia F. Hum Reprod.;30(9):1995;2015 648. Clarification of scope for Human Reproduction and Molecular Human Reproduction†. Petraglia F, Barratt CL, Evers JL. Hum Reprod Update.;21(5):559;2015 649.Expression, localization and control of activin A release from human umbilical vein endothelial cells. Borges LE, Bloise E, Dela Cruz C, Massai L, Ciarmela P, Apa R, Luisi S, Severi FM, Petraglia F, Reis FM. Growth Factor.; 33(4):243-9;2015 650.Serum markers for the noninvasive diagnosis of endometriosis. Luisi S, Pinzauti S, Regini C, Petraglia F. Womens Health (Lond Engl); 11(5):603-10;2015 651.Impact of Laparoscopic Surgical Management of Deep Endometriosis on Pregnancy Rate. Centini G, Afors K, Murtada R, Argay IM, Lazzeri L, Akladios CY, Zupi E, Petraglia F, Wattiez A. J Minim Invasive Gynecol.;(15)01556-3;2015 652. Management of fibroids in perimenopausal women. Giannubilo SR, Ciavattini A, Petraglia F, Castellucci M, Ciarmela P. Curr Opin Obstet Gynecol.;27(6):416-21;2015


87

653.Urocortin 1 expression and secretion by human umbilical vein endothelial cells: In vitro effects of interleukin 8, interferon γ, lipopolysaccharide, endothelin 1, prostaglandin F-2α, estradiol, progesterone and dexamethasone. Borges LE, Bloise E, Dela Cruz C, Galleri L, Apa R, Petraglia F, Reis FM. Peptides.;74:64-9;2015 654. Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines. Novembri R, De Clemente C, Funghi L, Torricelli M, Voltolini C, Challis JR, Petraglia F. Eur J Obstet Gynecol Reprod Biol.;195:200-2015 655. Naproxen sodium decreases prostaglandins secretion from cultured human endometrial stromal cells modulating metabolizing enzymes mRNA expression. Carrarelli P, Funghi L, Bruni S, Luisi S, Arcuri F, Petraglia F. Gynecol Endocrinol;3:1-4;2015 656.Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Vannuccini S, Clifton VL, Fraser IS, Taylor HS, Critchley H, Giudice LC, Petraglia F. Hum Reprod Update.;22(1):104-15;2016 657.Human Reproduction Update: double digits and beyond. Petraglia F. Hum Reprod Update.;22(1):1;2016 658. Expression of microtubule associated protein 2 and synaptophysin in endometrium: high levels in deep infiltrating endometriosis lesions. Gori M, Luddi A, Belmonte G, Piomboni P, Tosti C, Funghi L, Zupi E, Lazzeri L, Petraglia F. Fertil Steril.;105(2):435-43;2016 659. AISF position paper on liver disease and pregnancy. Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Liver AISF. Dig Liver Dis.;48(2):120-37;2016 660. Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions. Filippi I, Carrarelli P, Luisi S, Batteux F, Chapron C, Naldini A, Petraglia F. Reprod Sci; 23(4):492-7;2016 661.Modern operative hysteroscopy. Centini G, Troia L, Lazzeri L, Petraglia F, Luisi S. Minerva Ginecol.;68(2):126-32;2016


88

662.Office hysteroscopy: an update. Petraglia F, Luisi S. Minerva Ginecol.;68(2):124-5;2016 663. Potential influence of in utero and early neonatal exposures on the later development of endometriosis. Vannuccini S, Lazzeri L, Orlandini C, Tosti C, Clifton VL, Petraglia F. Fertil Steril.;105(4):997-1002;2016 664.CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration adhesion and migration. Galvagni F, Nardi F, Maida M, Bernardini G, Vannuccini S, Petraglia F, Santucci A, Orlandini M. Oncotarget. ;7(9):10090-103;2016 665.Tissue-Specific Cultured Human Pericytes: Perivascular Cells from Smooth Muscle Tissue Have Restricted Mesodermal Differentiation Ability. Pierantozzi E, Vezzani B, Badin M, Curina C, Severi FM, Petraglia F, Randazzo D, Rossi D, Sorrentino V. Stem Cells Dev.;25(9):674-86;2016

Prof. Felice Petraglia - WordPress.com · 2016-05-16 · 2000-2016 Direttore della Clinica...

Documents

Transcript of Prof. Felice Petraglia - WordPress.com · 2016-05-16 · 2000-2016 Direttore della Clinica...